var data={"title":"The placental pathology report","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">The placental pathology report</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/contributors\" class=\"contributor contributor_credentials\">Drucilla J Roberts, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/contributors\" class=\"contributor contributor_credentials\">Charles J Lockwood, MD, MHCM</a></dd><dd><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/contributors\" class=\"contributor contributor_credentials\">Rochelle L Garcia, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/contributors\" class=\"contributor contributor_credentials\">Vanessa A Barss, MD, FACOG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 28, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A placental examination permits the clinician to study the intrauterine environment of the fetus and some of the fetal responses to disease. Its examination is an essential component of the autopsy in cases of fetal or neonatal death, provides insights about the pathogenesis of adverse fetal and neonatal outcomes, and often gives useful information for diagnosis and treatment of sick newborns.</p><p>Providing a clear and succinct report is essential for the clinician. The author strongly suggests that the placental pathology report be included in both the infant's and the mother's medical charts. Having a routine standard gross and histologic evaluation and report is extremely helpful for all clinicians involved in counseling the family and improving neonatal care [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/1-3\" class=\"abstract_t\">1-3</a>]. An important secondary gain related to well-performed and reported placental examination is the avoidance of litigation [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/4\" class=\"abstract_t\">4</a>].</p><p>This topic will provide a brief synopsis of the clinical significance of selected placental histopathologic findings that are reported by placental pathologists. A detailed discussion of placental histopathology is beyond the scope of this review. The normal anatomy and gross examination of the placenta are discussed separately. (See <a href=\"topic.htm?path=gross-examination-of-the-placenta\" class=\"medical medical_review\">&quot;Gross examination of the placenta&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H13522917\"><span class=\"h1\">INDICATIONS FOR PLACENTAL PATHOLOGY EXAMINATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placental pathology offers insight into both acute and chronic events. We believe that all placentas should have a minimal examination including color, length of umbilical cord, number of cord vessels, and weight of the trimmed placental disk. Complete gross and histopathologic examination of the placenta should be obtained when clinically indicated. At a minimum, the author believes the following clinical scenarios require a full pathologic examination of the placenta:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stillbirth (current or past)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neonatal resuscitation or neonatal intensive care unit (NICU) admission</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preterm or post-term delivery</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multiple gestation</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any Apgar score &lt;7</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Obstetric <span class=\"nowrap\">complications/disorders</span> (eg, chorioamnionitis, preterm birth, preeclampsia, cholestasis, fetal intolerance of labor, antepartum or postpartum hemorrhage, thick meconium, severe <span class=\"nowrap\">oligohydramnios/polyhydramnios)</span></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abnormal gross examination of the placenta (eg, abnormal color, masses, long or short umbilical cord, abnormal membranes)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><span class=\"nowrap\">Fetal/neonatal</span> anomalies or hydrops</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Small for gestational <span class=\"nowrap\">age/large</span> for gestational age</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Relevant maternal <span class=\"nowrap\">diseases/disorders</span> (eg, diabetes, obesity, hypertension, <span class=\"nowrap\">tobacco/alcohol/illegal</span> drug use, thyroid disease, malignant neoplasm, <span class=\"nowrap\">fever/infection,</span> uterine anomalies or scars)</p><p/><p class=\"headingAnchor\" id=\"H63689380\"><span class=\"h1\">THE PLACENTAL PATHOLOGY REPORT</span></p><p class=\"headingAnchor\" id=\"H2283755665\"><span class=\"h2\">Overview</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The placental pathology report describes the gross and microscopic placental findings to clinicians involved in maternal and infant care. Placental pathology should be reported as a usual surgical pathology specimen; therefore, reports should be available within several days. These reports serve three broad functions: (1) providing information that helps to explain complications that occurred during the pregnancy, (2) providing information that should prompt immediate intervention (eg, previously unrecognized infection), <span class=\"nowrap\">and/or</span> (3) providing information that is predictive of future maternal or offspring problems.</p><p>The language of the report should be direct and non-inflammatory. Interpretation should be data-driven and not anecdotal; however, some expert opinion in a comment or a phone call, which is documented in a note, may be useful to help pull seemingly disparate findings together. Over-interpretation should be avoided. </p><p>Any findings with immediate clinical import should be brought promptly to the attention of the appropriate obstetric provider, <span class=\"nowrap\">and/or</span> pediatric provider when appropriate. The rare diagnoses that require clinical intervention should be phoned to the clinician as a critical value, and include such diagnoses as malignant neoplasms, specific infections, and inborn errors of metabolism. </p><p>Other important findings provide an estimate of risk for the neonatal and pediatric outcome, especially neurologic abnormalities, and include features associated with severe hypertensive disease (placental malperfusion), diffuse chorionic plate hemosiderosis, fetal thrombotic vasculopathy, fetal inflammatory response, meconium myonecrosis, diffuse villitis of unknown etiology, and massive perivillous fibrin deposition (maternal floor infarction).</p><p class=\"headingAnchor\" id=\"H434561749\"><span class=\"h2\">Gross description and final diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The placental pathology report should include a complete gross description and a final histopathological diagnosis. In the author&rsquo;s opinion, the first sentence of the gross description should include two basic findings, the maturity of the placenta (immature or mature) and the placental weight (weight in grams and percentile for gestational age), followed by the diagnoses. (See <a href=\"#H4072676570\" class=\"local\">'Placental maturity and weight'</a> below.)</p><p>Microscopic descriptions are variably included, but pertinent microscopic findings should be provided with the final diagnosis. Many histopathological diagnoses are descriptors of unclear clinical significance, but pathologic nonetheless. Clinically important findings should be included with the descriptors. The clinician reading the pathology report should review the diagnoses and call the pathologist to clarify, if needed.</p><p>The following is an example of the diagnostic section of a placental pathology report:</p><p>&ldquo;Diagnosis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immature placenta (215 g, ~10<sup>th</sup> percentile for reported gestational age of 28 weeks)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Long hyper-coiled umbilical cord (cord length 75 cm; normally expect about 45 cm at 28 weeks)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fetal vascular malperfusion (multiple large regions of avascular villi)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Villitis of unknown etiology, low grade</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Small placental infarct, usual type</p><p/><p>Comment: The long hyper-coiled umbilical cord is the likely source of the fetal vascular malperfusion, as long umbilical cords are associated with slow flow, heart failure, and cord occlusive events.&rdquo;</p><p class=\"headingAnchor\" id=\"H1173795429\"><span class=\"h1\">PLACENTAL FINDINGS</span></p><p class=\"headingAnchor\" id=\"H4072676570\"><span class=\"h2\">Placental maturity and weight</span></p><p class=\"headingAnchor\" id=\"H2761470833\"><span class=\"h3\">Maturity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placental villi mature across gestation; full maturity is normally attained by mid-third trimester. The maturational level of the placenta correlates with the functionality of the placenta: villous maturation should be appropriate for gestational age.</p><p>Maturity is defined by histologic features in the terminal villi. As the placenta grows, the villi branch and bud off from the initial stem villi to secondary, tertiary, and terminal villi. Each successive <span class=\"nowrap\">branch/bud</span> results in smaller villi, with the fetal vessels occupying more of the stroma. The trophoblast thins, forms knots, and eventually fuses with the villous capillaries to make a vasculosyncytial membrane (<a href=\"image.htm?imageKey=OBGYN%2F62758\" class=\"graphic graphic_picture graphicRef62758 \">picture 1</a>). This maturation process facilitates oxygen and nutrient transport to meet the demand of the near-term fetus.</p><p>An immature placenta will have immature villi without the vasculosyncytial membrane or numerous trophoblastic knots; this is a normal finding up to approximately the 32<sup>nd</sup> week of gestation. After about 32 weeks, the placental villi should have a predominance of small terminal villi with abundant knots and vasculosyncytial membranes. Identification of mature villi in a preterm gestation (ie, before 32 weeks) suggests placental ischemia. Identification of immature villi late in gestation (ie, at term) suggests the placenta was less efficient in gas and nutrient exchange, and may be a sign of maternal anemia or diabetes mellitus [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/5\" class=\"abstract_t\">5</a>].</p><p>Delayed villous maturation (also referred to as villous maturational arrest and distal villous immaturity) refers to a term placenta that has a paucity or absence of terminal villi, such that most of the villi are intermediate in size with increased capillaries and an absence or paucity of vasculosyncytial membranes (<a href=\"image.htm?imageKey=OBGYN%2F72450\" class=\"graphic graphic_picture graphicRef72450 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/6\" class=\"abstract_t\">6</a>]. This is an important diagnosis due to its association with maternal diabetes and fetal mortality [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/7,8\" class=\"abstract_t\">7,8</a>], even though the diagnosis can be quite subjective [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/9\" class=\"abstract_t\">9</a>]. There also may be an increased prevalence in pregnancies complicated by maternal opioid dependence [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/10\" class=\"abstract_t\">10</a>]. The link to fetal demise is possibly because the absence of vasculosyncytial membranes increases the distance (ie, decreases the efficiency) of <span class=\"nowrap\">oxygen/nutrient</span> transfer to the fetus, resulting in decreased placental capacity to meet fetal demands [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/7\" class=\"abstract_t\">7</a>]. </p><p>A contrasting important maturational pathology is hypermaturation, called distal villous hypoplasia, where the villi are inappropriately mature (small or elongated with increased intervillous space), and the intermediate villi are fewer. (See <a href=\"#H21\" class=\"local\">'Parenchymal infarcts, syncytial knotting, and other lesions associated with malperfusion'</a> below.)</p><p class=\"headingAnchor\" id=\"H665901411\"><span class=\"h3\">Weight</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The placental weight is a key part of the placental examination. It is a marker for placental development and capacity (reserve). Small placentas by weight are associated with less <span class=\"nowrap\">reserve/less</span> capacity to support fetal needs. Standards for placental weights at different gestational ages are available and should be reported with the actual weight (<a href=\"image.htm?imageKey=OBGYN%2F72177\" class=\"graphic graphic_table graphicRef72177 \">table 1</a>). The placenta must be weighed appropriately, trimmed of cord and membranes, for the percentiles and ratio to be reliable. (See <a href=\"topic.htm?path=gross-examination-of-the-placenta\" class=\"medical medical_review\">&quot;Gross examination of the placenta&quot;</a>.)</p><p>The weight of the placenta should normally correspond to the weight of the fetus. A normal <span class=\"nowrap\">fetal/placental</span> weight ratio at term is between 6 and 7; a ratio less than 6 is very unusual and suggests placental hydrops, and a ratio of &ge;8 suggests placental insufficiency.</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h2\">Umbilical cord</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The umbilical cord is the lifeline of the fetus so any umbilical cord lesion that may interfere with blood flow (eg, cord hyper-coiling, knots, hemorrhage, tumors, thrombi) is clinically important. The umbilical cord also reflects the in utero environment (eg, meconium, infection, stress) and the fetal response to its environment (eg, vasculitis). However, some findings have no clinical significance, such as congenital remnants. </p><p>Umbilical cord gross and histopathologic findings are also reviewed in the following topics:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=gross-examination-of-the-placenta#H4\" class=\"medical medical_review\">&quot;Gross examination of the placenta&quot;, section on 'Umbilical cord'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=prenatal-diagnosis-and-management-of-umbilical-cord-abnormalities\" class=\"medical medical_review\">&quot;Prenatal diagnosis and management of umbilical cord abnormalities&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=velamentous-umbilical-cord-insertion-and-vasa-previa\" class=\"medical medical_review\">&quot;Velamentous umbilical cord insertion and vasa previa&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=care-of-the-umbilicus-and-management-of-umbilical-disorders\" class=\"medical medical_review\">&quot;Care of the umbilicus and management of umbilical disorders&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=prenatal-diagnosis-and-management-of-umbilical-cord-abnormalities\" class=\"medical medical_review\">&quot;Prenatal diagnosis and management of umbilical cord abnormalities&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H63689559\"><span class=\"h3\">Cord coiling</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The normal umbilical cord <span class=\"nowrap\">twists/coils</span> a full 360 degrees over about every 5 cm of length, resulting in a cord coiling index (coils per centimeter) of approximately 0.2; the cord typically coils to the left. </p><p>Although the etiology of cord coiling is not completely understood, abnormal cord coiling is associated with antenatal complications. Flat umbilical cords have been associated with decreased fetal activity due to any etiology and thus have an association with neuromuscular abnormalities [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/11-13\" class=\"abstract_t\">11-13</a>]. Hyper-coiled cords have been associated with sudden fetal death due to cord <span class=\"nowrap\">constrictions/flow</span> obstruction. Four coiling patterns have been described: undulating, rope, segmented, and linked; the linked pattern is most associated with fetal morbidity (<a href=\"image.htm?imageKey=OBGYN%2F93966\" class=\"graphic graphic_figure graphicRef93966 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/11\" class=\"abstract_t\">11</a>]. Hypo- and hyper-coiled cords should be listed as a part of the diagnosis in the placental pathology report since they can be associated with adverse fetal outcomes. </p><p class=\"headingAnchor\" id=\"H63689566\"><span class=\"h3\">Insertional anomalies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Marginal or membranous insertions of the umbilical cord are associated with an increased risk of adverse perinatal outcomes (eg, fetal growth restriction, fetal death) and should be reported in the placental pathology report. (See <a href=\"topic.htm?path=velamentous-umbilical-cord-insertion-and-vasa-previa\" class=\"medical medical_review\">&quot;Velamentous umbilical cord insertion and vasa previa&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h3\">Inflammation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Umbilical cord inflammation has many names, including funisitis and vasculitis. Inflammatory cells migrating through the fetal cord vessels (<a href=\"image.htm?imageKey=OBGYN%2F74438\" class=\"graphic graphic_picture graphicRef74438 \">picture 3</a>) or chorionic plate vessels are evidence of a fetal response and are diagnostic of systemic fetal inflammatory response syndrome [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/14\" class=\"abstract_t\">14</a>]. Typically, the fetal inflammatory response starts by inflammatory cell migration to the periphery of the lumen of chorionic plate vessels, then transgressing through the endothelium, vascular muscular wall, and then into the mesoderm surrounding the vessel (chorionic plate mesoderm in the chorionic plate). With time, the umbilical vein becomes involved (umbilical cord phlebitis), Wharton jelly in the umbilical cord, and finally the umbilical arteries. </p><p>An inflammatory infiltrate involving only the external surface of the cord and superficial Wharton jelly originates from the mother; the maternal inflammatory cells (primarily neutrophils) migrate from the decidua to the amniotic fluid and then to the cord. </p><p>The source (maternal or fetal) of the inflammatory response is important because there is a greater risk of neurologic compromise in offspring when the inflammatory response is fetal since fetal inflammation of the umbilical cord may be a marker for infection or possibly vascular inflammation elsewhere in the fetus [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/15,16\" class=\"abstract_t\">15,16</a>]. A <span class=\"nowrap\">marked/severe</span> fetal inflammatory response with prominent eosinophilia admixed with neutrophils in areas of fetal inflammation is particularly predictive of an adverse neonatal outcome, especially when preterm [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/17\" class=\"abstract_t\">17</a>]. (See <a href=\"topic.htm?path=placental-pathology-in-cases-of-neurologically-impaired-infants\" class=\"medical medical_review\">&quot;Placental pathology in cases of neurologically impaired infants&quot;</a>.). </p><p class=\"headingAnchor\" id=\"H4261072954\"><span class=\"h3\">Nonbacterial infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The umbilical cord is the site for some specific nonbacterial infectious organisms including candida (<a href=\"image.htm?imageKey=OBGYN%2F53199\" class=\"graphic graphic_picture graphicRef53199 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/14\" class=\"abstract_t\">14</a>] and toxoplasmosis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/14\" class=\"abstract_t\">14</a>]. Although much less common than bacterial infection, these organisms can sometimes be observed in the areas of inflammation. Candidal infection is frequently associated with neutrophilic microabscesses on the external surface of the umbilical cord (see <a href=\"#H87579796\" class=\"local\">'Candida'</a> below). </p><p>The only viral infection known to affect the umbilical cord in herpes simplex virus. In these cases, you might see a plasma cell infiltrate or cells with viral inclusions in Wharton&rsquo;s jelly.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Meconium staining</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>All fetuses after about 20 weeks of gestation can pass meconium. In preterm fetuses, meconium passage is considered a stress-related response. At term, and especially post-term, meconium passage may be physiologic and is not necessarily a stress response. Freshly passed meconium may coat the membranes, cord, and neonatal skin. Abundant meconium in the membranes at any gestational age is usually associated with a significant fetal insult.</p><p>A high concentration of meconium present for more than 12 hours can damage the umbilical cord by causing apoptosis of smooth muscle cells [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/18\" class=\"abstract_t\">18</a>]. The histologic findings are an orangeophilic apoptotic-like degeneration of the arteries (usually) in a characteristic pattern that spares the centrally-facing myocytes (<a href=\"image.htm?imageKey=OBGYN%2F67487\" class=\"graphic graphic_picture graphicRef67487 \">picture 5</a>). An inflammatory infiltrate is often present. In addition, meconium-induced vasoconstriction has been documented in vitro, which may further compromise blood flow through the umbilical cord [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/19\" class=\"abstract_t\">19</a>].</p><p>In retrospective studies, meconium-induced umbilical cord vascular necrosis has been associated with postterm pregnancy, oligohydramnios, low cord pH, low Apgar scores, and significant neurodevelopmental delay [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/18,20-22\" class=\"abstract_t\">18,20-22</a>]. Fetal and neonatal morbidity is thought to be due to interruption of the normal blood flow in the cord from the meconium-induced vascular damage, causing intermittent or prolonged hypoxia. There are no prospective studies to establish whether this finding should cause concern and early postdelivery intervention, but the author typically notifies the infant&rsquo;s pediatrician of the finding.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Solid and cystic abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common mass of the umbilical cord is a hematoma (<a href=\"image.htm?imageKey=OBGYN%2F70927\" class=\"graphic graphic_picture graphicRef70927 \">picture 6</a> and <a href=\"image.htm?imageKey=OBGYN%2F56907\" class=\"graphic graphic_picture graphicRef56907 \">picture 7</a>). These are usually a sequela of cord clamping and traction, and of no clinical significance since it is an iatrogenic postdelivery event. </p><p>Spontaneous cord hematomas are rare and clinically significant, as they are usually associated with fetal death due to exsanguination or to compression of umbilical cord vessels by the hematoma. The cause is generally not identifiable, although, in the author&rsquo;s experience, vascular damage (eg, meconium myonecrosis, inflammatory damage) is almost always present. </p><p>The umbilical cord is also host to rare neoplasms, including mature cystic teratomas [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/23-25\" class=\"abstract_t\">23-25</a>], hemangiomas [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/26-28\" class=\"abstract_t\">26-28</a>] and angiomyxomas [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/29,30\" class=\"abstract_t\">29,30</a>], and non-neoplastic intestinal-type polyps (ie, polypoid intestinal masses that probably develop within the vitelline duct remnant) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/31\" class=\"abstract_t\">31</a>]. If large, any of these masses can cause fetal morbidity or death in utero, due to <span class=\"nowrap\">compression/obstruction</span> of the umbilical cord vessels.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Arterial and venous thrombosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Umbilical artery and umbilical vein thrombosis are rare, but can compromise the fetal circulation [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/32-35\" class=\"abstract_t\">32-35</a>]. Venous thrombosis occurs alone in approximately 70 percent of cases, both venous and arterial thrombosis occurs in approximately 20 percent of cases, and arterial thrombosis occurs alone in 10 percent of cases [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/36\" class=\"abstract_t\">36</a>].</p><p>Arterial thromboses in one part of the cord can result in the appearance of a single umbilical artery (two-vessel cord) in another part of the cord. As long as one patent artery remains, the outcome is not lethal, but an adverse outcome may occur if the thrombus embolizes to the placenta and results in fetal thrombotic vasculopathy, which if significant, might result in fetal growth restriction or intrapartum hypoxemia or acidosis due to decreased placental reserve.</p><p>Umbilical vein thrombosis will be fatal if complete; partial thrombi can embolize to the fetus and cause cerebral or renal infarcts, or damage to other end-organs, including amputations of digits.</p><p>Possible causes of umbilical vessel thrombosis include mechanical obstruction (eg, hyper-twisting, knots, prolapse, amniotic bands, velamentous cord insertion, varices); fetal thrombophilia; meconium-induced vascular necrosis; severe inflammation (funisitis); and iatrogenic injury [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/34,37\" class=\"abstract_t\">34,37</a>], but many cases remain unexplained.</p><p class=\"headingAnchor\" id=\"H4507457\"><span class=\"h3\">Single umbilical artery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Single umbilical artery may be a developmental anomaly or result from remote <span class=\"nowrap\">thrombosis/occlusion</span>. Its clinical significance is its weak association with congenital renal anomalies. (See <a href=\"topic.htm?path=single-umbilical-artery\" class=\"medical medical_review\">&quot;Single umbilical artery&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1173795986\"><span class=\"h3\">Congenital remnants</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The proximal end of the umbilical cord (the end closest to the infant) often contains residual developmental structures, such as the allantoic and vitelline (omphalomesenteric) ducts [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/38\" class=\"abstract_t\">38</a>]. Allantoic duct remnants are common and have no clinical significance, except in rare cases where they are enlarged and a marker for a patent urachus. Vitelline duct and vitelline vessel remnants also have no clinical significance, except in rare cases where there is a direct connection to fetal bowel.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Membranes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gross and microscopic findings in the fetal membranes are critical aspects of the placental report. The membranes may show evidence of abnormal constituents of the amniotic fluid (eg, meconium, bacteria, inflammatory cells, blood), oligohydramnios, or fetal malformations (eg, gastroschisis, exstrophies, ectopia cordis).</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Acute or chronic chorioamnionitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neutrophilic (acute) inflammation is probably one of the most common pathologic findings during placental examination and is present in as many as one-quarter of all term placentas. Contamination of amniotic fluid by <span class=\"nowrap\">vaginal/cervical</span> flora [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/39\" class=\"abstract_t\">39</a>] may result in a maternal inflammatory response; a fetal inflammatory response can also occur [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/40-42\" class=\"abstract_t\">40-42</a>]. Acute chorioamnionitis should be diagnosed by staging and grading the maternal and fetal inflammatory response using the Amsterdam and Redline criteria [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/6,15\" class=\"abstract_t\">6,15</a>]. (See <a href=\"#H4\" class=\"local\">'Inflammation'</a> above and <a href=\"#H18\" class=\"local\">'Villitis'</a> below and <a href=\"#H87576253\" class=\"local\">'Chorioamnionitis'</a> below.)</p><p>Chronic chorioamniotic inflammation is characterized by a mononuclear cell infiltrate (ie, lymphocytes, histiocytes and plasma cells). Compared to the neutrophilic &quot;acute&quot; form, which is usually due to bacterial infection, immune mediated inflammation has a different, and usually non-infectious, etiology [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/43,44\" class=\"abstract_t\">43,44</a>]. It is often associated with chronic villitis, specifically villitis of unknown etiology (VUE) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/44\" class=\"abstract_t\">44</a>] and has the same clinical associations.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Meconium staining</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>All fetuses after about 20 weeks of gestation can pass meconium. In preterm fetuses, meconium passage is considered a stress-related response. At term, and especially postterm, meconium passage may be physiologic and is not necessarily a stress response. Freshly passed meconium may coat the membranes, cord, and neonatal skin.</p><p>Meconium pigment is derived primarily from the bile pigment it contains. This pigment varies from a fluffy, light brown material to a waxy, uniform, opaque pigment (<a href=\"image.htm?imageKey=OBGYN%2F53101\" class=\"graphic graphic_picture graphicRef53101 \">picture 8</a>) that is present in macrophages. These differences in macrophage appearance are not related to the exposure history or the clinical course.</p><p>Meconium appears to be toxic since it can cause amniotic epithelial necrosis, myocyte necrosis, and, in the author&rsquo;s opinion, a marked fetal inflammatory infiltrate in the fetal cord vessels <span class=\"nowrap\">and/or</span> membranes in the absence of acute chorioamnionitis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/18,21,22,45\" class=\"abstract_t\">18,21,22,45</a>]. (See <a href=\"#H17\" class=\"local\">'Parenchyma'</a> below.)</p><p>Infant morbidity from meconium can occur from inhalation due to gasping in utero or at birth or from umbilical vascular damage due to prolonged exposure in utero. The degree of vascular damage relates to the length of exposure: it takes at least one hour for meconium pigment to be present in the amnion; three hours for the pigment to appear in the chorion; six hours to cause amniocyte necrosis; and more than 12 hours to cause myocyte necrosis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/18,20-22,45-50\" class=\"abstract_t\">18,20-22,45-50</a>].</p><p class=\"headingAnchor\" id=\"H4505987\"><span class=\"h3\">Hemosiderin staining</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Not all brown pigment in the membranes is meconium. Blood in the amniotic fluid from chronic abruption can cause hemosiderin deposition in the amniotic macrophages. This pigment differs from meconium because of its yellow-brown and crystalline hue, obviating the necessity for special stains in most cases. The author obtains iron stains when the clinical history suggests passage of meconium or in-utero stress or in suspicious cases, such as when the brown pigment is copper-colored or birefringent, pigment deposition is excessive, or when the gestational age is less than 30 weeks. </p><p>Diffuse chorionic hemosiderosis is a dramatic histologic presentation of extensive hemosiderin involving the chorionic plate. It is a feature of chronic abruption [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/51,52\" class=\"abstract_t\">51,52</a>] and has been associated with significant perinatal morbidity [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/53,54\" class=\"abstract_t\">53,54</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Solid and cystic abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>No true neoplasms affect the fetal membranes, although extension of rare umbilical cord neoplasms can involve the adjacent chorionic plate. Cysts on the surface of the amnion may result from localized edema, and are not usually associated with clinical disease or sequelae. Cysts of the chorionic plate or septa are usually benign, although multiple or large cysts are associated with increased fetal morbidity and mortality [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/55,56\" class=\"abstract_t\">55,56</a>].</p><p>Remnants of the yolk sac are relatively common and benign. They present as one or more approximately 5 mm yellow-white, well-circumscribed calcified masses beneath the amnion.</p><p>Subamniotic hematoma is generally iatrogenic, such as from cord traction at delivery. Subchorionic hematoma results from intervillous (maternal) bleeding, usually from marginal (uterine) blood vessels, and is associated with an increased risk of miscarriage and preterm birth when large or associated with hemosiderin in the membranes [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/51,57\" class=\"abstract_t\">51,57</a>].</p><p>Metaplasia of the amniotic epithelium (expanded cells with foamy microvesicular changes) may occur when fetal anomalies allow fetal viscera to make contact with the amnion (eg, exstrophies, ectopia cordis, gastroschisis) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/58,59\" class=\"abstract_t\">58,59</a>]. Other metaplasias (squamous, papillary, columnar) are common and of no clinical significance, but may indicate amniotic &quot;irritation&quot; as in acute chorioamnionitis or meconium exposure.</p><p>White, brown, or yellow nodules on the amnion may be due to amnion nodosum [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/58\" class=\"abstract_t\">58</a>]. Amnion nodosum is caused by abrasion of the amnion with deposition of fetal squamous cells and acellular debris on the eroded areas (<a href=\"image.htm?imageKey=OBGYN%2F78284\" class=\"graphic graphic_picture graphicRef78284 \">picture 9</a>) in the setting of severe and prolonged oligohydramnios, and usually associated with anhydramnios. The membranes on the placental surface are most affected, while the umbilical cord is rarely affected.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Parenchyma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Parenchymal lesions can result from either a fetal or maternal source since both circulations perfuse the placenta, or may be unique to the placenta itself (eg, mesenchymal dysplasia [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/60\" class=\"abstract_t\">60</a>]). Some parenchymal findings have been associated with neurologic impairment and cerebral palsy in children. (See <a href=\"topic.htm?path=placental-pathology-in-cases-of-neurologically-impaired-infants\" class=\"medical medical_review\">&quot;Placental pathology in cases of neurologically impaired infants&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h3\">Villitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both neutrophilic (acute) and lympho-histiocytic (chronic) villitis are inflammatory infiltrates involving the placental parenchyma. The specific diagnosis is based upon the nature and type of inflammatory infiltrate and probable cause.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h4\">Acute villitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><span class=\"nowrap\">Neutrophilic/acute</span> villitis is a specific gross and histologic feature of <span class=\"nowrap\">micro/macro</span> neutrophilic abscesses in the placental parenchyma and is often accompanied by neutrophilic chorioamnionitis (<a href=\"image.htm?imageKey=OBGYN%2F56641\" class=\"graphic graphic_picture graphicRef56641 \">picture 10</a>). It is typically associated with a bacterial infection, almost always secondary to listerial infections, but sometimes due to streptococci [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/18,21,22,45\" class=\"abstract_t\">18,21,22,45</a>] and rarely others.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h4\">Lympho-histiocytic (chronic) villitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic villitis refers to a mononuclear (primarily lymphohistiocytic) cell infiltrate within or around the villi (<a href=\"image.htm?imageKey=OBGYN%2F77237\" class=\"graphic graphic_picture graphicRef77237 \">picture 11</a>) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/61,62\" class=\"abstract_t\">61,62</a>]. Most cases are not caused by infection, but the specific cause of these chronic villitis cases is unknown, hence the term &ldquo;villitis of unknown etiology&rdquo; or VUE. VUE should be graded according to the Amsterdam criteria [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/6\" class=\"abstract_t\">6</a>], as it is likely only high-grade VUE that is important clinically. High-grade VUE has been associated with fetal growth restriction, fetal death, abnormal brain findings on neonatal magnetic resonance imaging (MRI), and spastic quadriplegic cerebral palsy [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/54,63,64\" class=\"abstract_t\">54,63,64</a>]. Therefore, severe diffuse VUE is an important diagnosis to report to both the obstetrician and the pediatrician. In contrast, focal or patchy VUE (<a href=\"image.htm?imageKey=OBGYN%2F95039\" class=\"graphic graphic_picture graphicRef95039 \">picture 12</a>) is a common, usually nonspecific, finding detected in approximately 5 to 10 percent of term placentas [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/43,65\" class=\"abstract_t\">43,65</a>] and likely not clinically relevant in a placenta of normal weight.</p><p>One hypothesis for VUE is that it is a response of the maternal host to the fetal allograft. The mononuclear cells are maternal in origin and are probably responding to a fetal antigen expressed by the villi [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/66\" class=\"abstract_t\">66</a>]. In some cases, the fetus is compromised by necrosis of the villi by maternal white cells; this process is commonly manifested clinically as intrauterine growth restriction [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/67,68\" class=\"abstract_t\">67,68</a>]. It is also possible that products of villous inflammation enter the fetal vasculature and have a systemic effect on fetal growth [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/69\" class=\"abstract_t\">69</a>]. This type of villitis has been associated with infertility, untreated neonatal alloimmune thrombocytopenia, and neonatal neurological impairment (when associated with obliterative fetal vasculopathy) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/67,70-72\" class=\"abstract_t\">67,70-72</a>]. It recurs in future pregnancies in approximately one third of cases [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/73\" class=\"abstract_t\">73</a>].</p><p>Infection is the definitive cause of a small (less than 5 percent) subset of cases of lympho-histiocytic villitis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/74-76\" class=\"abstract_t\">74-76</a>]. TORCH infections (ie, Toxoplasmosis, Other, Rubella, Cytomegalovirus, Herpes) are the usual source. This type of villitis is associated with other abnormal pathological or clinical findings, such as plasma cell deciduitis, stillbirth, fetal growth restriction, or hydrops. The diagnosis is made by routine hematoxylin-eosin or immunohistochemical stains for viral markers or spirochetes. When associated with TORCH infections, villitis is usually multifocal and may have some of the following histologic features:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased cellularity of the villi</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sclerosis of the villi due to collapse of the villous vessels</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clumping of the involved villi</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fetal normoblastemia (circulating fetal immature nucleated red blood cells)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemosiderin in the villi</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plasma cells in the villi</p><p/><p>On low-power histopathology, these changes will appear as multifocal clusters of dark blue cellular avascular villi, often clumped together and surrounded by fibrin (<a href=\"image.htm?imageKey=OBGYN%2F64413\" class=\"graphic graphic_picture graphicRef64413 \">picture 13</a>). The inflammatory infiltrate in viral infections is typically mononuclear and typically contains histiocytes (sometimes multi-nucleate), lymphocytes, and plasma cells. The inflammatory cells are maternal in origin and may &quot;spill out&quot; of the villi to cause an intervillositis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/66\" class=\"abstract_t\">66</a>]. At higher magnification, a viral inclusion (eg, cytomegalovirus [CMV]) (<a href=\"image.htm?imageKey=OBGYN%2F70713\" class=\"graphic graphic_picture graphicRef70713 \">picture 14</a>), granuloma, or giant cells may be detected that help to determine a more precise etiology for the infection. Clinically, a small mature placenta with severe, diffuse, plasmacytic villitis associated with a small for gestational age neonate should prompt consideration of&nbsp;CMV infection primarily, and herpes simplex virus (HSV) or toxoplasmosis secondarily.</p><p>An infectious villitis in a liveborn is a critical finding to be reported urgently to the obstetrician and pediatrician. In a stillborn, it explains the loss and is therefore important to report.</p><p class=\"headingAnchor\" id=\"H4508589\"><span class=\"h3\">Chorangiosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chorangiosis refers to a vast increase in the number of vascular channels in noninfarcted, nonischemic areas of the placenta [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/77\" class=\"abstract_t\">77</a>]. When diffuse, it is uncommon and thought to be related to long-standing hypoxia. It is also seen with maternal tobacco smoking, high altitude pregnancies, multiple gestations, and maternal diabetes [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/5,78-80\" class=\"abstract_t\">5,78-80</a>]. It has been associated with stillbirth, cord problems, and congenital anomalies [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/77,81-83\" class=\"abstract_t\">77,81-83</a>]. Chorangiosis can be confused with placental villous congestion but, in the latter, the vessels are distended without an increase in number of vessels per villus.</p><p class=\"headingAnchor\" id=\"H4507183\"><span class=\"h3\">Excessive fibrin deposition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Excessive fibrin deposition is a key finding in maternal floor infarction <span class=\"nowrap\">(MFI)/massive</span> perivillous fibrin deposition (MPFD) and chronic histiocytic intervillositis (CHI). Both parenchymal disorders are associated with perinatal morbidity and mortality, and recurrence. They are probably related to, or part of, a spectrum of maternal immunologic dysfunction. However, a small amount of perivillous fibrinoid is a normal finding with advancing gestation.</p><p class=\"headingAnchor\" id=\"H4507189\"><span class=\"h4\">Maternal floor infarction/massive perivillous fibrin deposition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The maternal floor corresponds to the anatomic region of the placental disk attached to the maternal surface of the uterine cavity. It includes the most basal villi, Nitabuch's membrane, the placental implantation site, and the decidual basalis. MFI refers to a process in which a thick band of fibrin is deposited along the maternal floor of the placenta, thereby obstructing maternal blood flow through the placenta to the fetal villi (<a href=\"image.htm?imageKey=OBGYN%2F59608\" class=\"graphic graphic_picture graphicRef59608 \">picture 15</a>). Thus, MFI is a misnomer, as the primary process is not infarction, but abnormal interface fibrin deposition. MFI is likely in continuum with MPFD; therefore, they are usually diagnosed with the single composite diagnosis <span class=\"nowrap\">MFI/MPFD</span> [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/84\" class=\"abstract_t\">84</a>]. </p><p>The lesion has been associated with both an elevated maternal serum alpha-fetoprotein and recurrence in subsequent pregnancies. The fetal sequelae include intrauterine growth restriction, stillbirth, and neurologic injury [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/85,86\" class=\"abstract_t\">85,86</a>] due to uteroplacental insufficiency. </p><p>The etiology of MFI is unknown, but is thought to be an extreme form of host versus graft reaction to the pregnancy [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/43,87-91\" class=\"abstract_t\">43,87-91</a>]. </p><p><span class=\"nowrap\">MFI/MPFD</span> recur in future pregnancies. The mother should be evaluated for a coagulopathy, particularly antiphospholipid syndrome [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/86,87,92\" class=\"abstract_t\">86,87,92</a>], as a possible cause of <span class=\"nowrap\">MVFI/MPFD,</span> and other autoimmune disorders [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/73\" class=\"abstract_t\">73</a>]. </p><p class=\"headingAnchor\" id=\"H4507195\"><span class=\"h4\">Chronic histiocytic intervillositis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic histiocytic intervillositis (CHI) refers to the presence of massive amounts of intervillous and perivillous fibrin associated with a marked maternal histiocyte infiltration (<a href=\"image.htm?imageKey=OBGYN%2F58193\" class=\"graphic graphic_picture graphicRef58193 \">picture 16</a>) usually in the absence of VUE. This lesion is distinctive in the term placenta, but is more commonly present in first and second trimester losses. It has been reported to recur in up to 80 percent of successive pregnancies, but the literature describing these cases is sparse [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/93-95\" class=\"abstract_t\">93-95</a>]. CHI has been seen in some infectious pathologies as well, including malaria [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/96\" class=\"abstract_t\">96</a>], Zika virus (in first-trimester placentas [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/97,98\" class=\"abstract_t\">97,98</a>]), Dengue virus [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/99\" class=\"abstract_t\">99</a>], and with acute inflammation in psittacosis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/73,100\" class=\"abstract_t\">73,100</a>]. </p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Parenchymal infarcts, syncytial knotting, and other lesions associated with malperfusion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Maternal vascular pathology can reduce or completely interrupt the uteroplacental circulation, resulting in placental infarcts, abruptio placentae, and ischemic lesions [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/101\" class=\"abstract_t\">101</a>]. Classically, histopathologic findings associated with maternal hypertensive diseases have been attributed to malperfusion, although the damage may be more related to hypertensive injury (pressure related) than to true malperfusion or ischemia [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/102-104\" class=\"abstract_t\">102-104</a>]. Chronic maternal malperfusion of fetal villi often results in a small (eg, placental weight is &lt;10<sup>th</sup> percentile) ischemic placenta [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/105-108\" class=\"abstract_t\">105-108</a>]. </p><p>Chronic malperfusion ultimately results in placental infarcts (<a href=\"image.htm?imageKey=OBGYN%2F51550\" class=\"graphic graphic_picture graphicRef51550 \">picture 17</a>). Infarcts consist of collapsed maternal intervillous spaces and necrotic villi, usually involving the maternal floor. These findings are nonspecific and can occur with maternal hypertensive disorders (preeclampsia, chronic hypertension), uterine anomalies, maternal cardiovascular disease, and maternal hereditary and acquired thrombophilias. Peripheral infarcts on the maternal side of the placenta are common at term and, if small, usually not clinically significant. Perinatal morbidity is associated with infarcts of more than 5 percent of the placental mass or greater than 3 cm in diameter [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/109,110\" class=\"abstract_t\">109,110</a>]. Infarcts are considered clinically severe (eg, associated with fetal growth <span class=\"nowrap\">restriction/stillbirth)</span> if 20 percent or more of the placenta is affected [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/111\" class=\"abstract_t\">111</a>] or if the placenta is small by weight. Infarcts are rare in preterm gestations and are associated with malperfusion; therefore, they are more clinically relevant.</p><p>Specific histopathologic findings that correlate with maternal vascular malperfusion include: increased syncytial knots (&gt;1 in 3 to 5 terminal villi <span class=\"nowrap\">and/or</span> &gt;10 nuclei per knot), large syncytial knots, villous agglutination (microinfarcts with villi collapsing on one another, especially in the center of the parenchyma not involving the maternal floor), distal villous hypoplasia (reduced numbers of intermediate villi resulting in increased intervillous space) (<a href=\"image.htm?imageKey=OBGYN%2F94964\" class=\"graphic graphic_picture graphicRef94964 \">picture 18</a>), increased intervillous fibrin (filling the slide), sclerotic narrowing of arteries and arterioles, and sheets of intermediate trophoblast along the basal plate [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/101\" class=\"abstract_t\">101</a>]; although the significance of the findings and their relationship to clinical disease are unclear [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/112-114\" class=\"abstract_t\">112-114</a>].</p><p class=\"headingAnchor\" id=\"H4510265\"><span class=\"h3\">Calcification</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Calcium deposits in fibrinoid in the floor and septa are a normal finding associated with diet and placental maturity at term and post-term. Villous calcification, however, is seen in villous necrosis and with excess perivillous fibrin deposition, which may be associated with pathological disorders such as infarction, CMV infection, thrombosis, and fetal death. A unique subtrophoblastic mineralization often seen in stillbirths is also a characteristic of <span class=\"nowrap\">fetal/neonatal</span> Bartter syndrome, and should be noted when present in livebirths [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/115,116\" class=\"abstract_t\">115,116</a>].</p><p>When seen in preterm placentas, calcification in the floor and septa has been attributed to senescence and, therefore, considered a feature of placental insufficiency (maternal vascular malperfusion). </p><p class=\"headingAnchor\" id=\"H87576228\"><span class=\"h3\">Langhans cells and Hofbauer cells</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Villous Langhans and Hofbauer cells are significant when increased in number, as this has been associated with placental immaturity and congenital Zika infection [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/117\" class=\"abstract_t\">117</a>]. (See <a href=\"#H2761470833\" class=\"local\">'Maturity'</a> above.)</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h3\">Fetal vascular malperfusion (FVM), also known as fetal thrombotic vasculopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathology associated with vascular flow abnormalities on the fetal side of the placenta are known to be significant indicators of fetal well-being and outcome [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/118\" class=\"abstract_t\">118</a>] and have been well-characterized and classified [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/78\" class=\"abstract_t\">78</a>]. When diagnosing FVM, the Amsterdam criteria for grading should be employed [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H4508407\"><span class=\"h4\">Thrombi in fetal vessels</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Organized mural occlusive or nonocclusive thromboemboli are occasionally noted in the fetal vessels of the placenta, including the umbilical cord, chorionic plate, and villi. Fetal vascular malperfusion (also known as fetal thrombotic vasculopathy) is nearly always present in placentas from stillbirths, but also occurs not infrequently in live births. The differential diagnosis includes: anatomic obstruction (true knots of the umbilical cord, membranous vessels), inflammatory injury to vessels (as in the &quot;phlebitis&quot; present in some cases of neutrophilic chorioamnionitis and the small vessels compromised in neutrophilic or lympho-histiocytic villitis), toxic causes (meconium myonecrosis, infant of insulin requiring diabetic mother), sepsis with disseminated intravascular coagulation, polycythemia, cardiac failure, and inherited fetal coagulopathy (eg, factor V Leiden) and congenital stroke [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/37,50,119-127\" class=\"abstract_t\">37,50,119-127</a>].</p><p>The presence of chorionic plate vascular thrombi should raise suspicions of congenital viral infections, especially in the setting of premature delivery, hydrops, stillbirth, or villitis. Both CMV and HSV placentitis have an association with chorionic plate vascular thrombi [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/128\" class=\"abstract_t\">128</a>].</p><p class=\"headingAnchor\" id=\"H4508414\"><span class=\"h4\">Avascular villi</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The villi become necrotic if the fetus stops perfusing them, but the maternal intervillous spaces are maintained since maternal blood flow is not affected. Avascular villi are usually the result of fetal vascular damage (eg, membranous cord insertion, severe chorioamnionitis with vascular involvement, chronic villitis) or fetal thromboemboli (<a href=\"image.htm?imageKey=OBGYN%2F77237\" class=\"graphic graphic_picture graphicRef77237 \">picture 11</a>).</p><p class=\"headingAnchor\" id=\"H4508421\"><span class=\"h4\">Villous stromal-vascular karyorrhexis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Villous stromal-vascular karyorrhexis (VSK), also termed hemorrhagic endovasculitis, hemorrhagic endovasculopathy, or hemorrhagic endovasculosis, refers to a particular type of FVM in which the villous vessels are often occluded and contain extravasated and fragmented red blood cells (<a href=\"image.htm?imageKey=OBGYN%2F50997\" class=\"graphic graphic_picture graphicRef50997 \">picture 19</a>). This lesion is thought to be due to slow flow from the fetus, as in cardiac failure or polycythemia. This finding is common among stillbirths, although, in these cases, it is difficult to conclude whether the finding proceeded, and may have contributed to, the fetal death (unless the finding is unevenly distributed).</p><p>VSK is also seen in live births, and has been associated with neurologic injury in these cases [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/129\" class=\"abstract_t\">129</a>]. It can be associated with other thrombotic lesions, and appears to be a form of fetal vascular malperfusion and a precursor of avascular villi. It has been proposed that the terms fetal vascular malperfusion and extensive avascular villi <span class=\"nowrap\">(and/or</span> VSK) be reserved for placentas with 15 or more affected terminal villi per section, and not include those with only scattered foci [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/130\" class=\"abstract_t\">130</a>]. VUE with stem villitis and avascular villi (obliterative VUE) is a distinct process with substantial perinatal morbidity. (See <a href=\"topic.htm?path=placental-pathology-in-cases-of-neurologically-impaired-infants#H19\" class=\"medical medical_review\">&quot;Placental pathology in cases of neurologically impaired infants&quot;, section on 'Active chronic placental disease'</a>.)</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h3\">Mass lesions of the parenchyma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Parenchymal masses may be due to intervillous thrombi (IVT), chorangioma, metastatic neoplasms, as well as infarcts and abscesses.</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h4\">Intervillous thrombi</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intervillous thrombi (IVT) are laminated red blood cells and fibrin that fill the maternal space separating the villi (<a href=\"image.htm?imageKey=OBGYN%2F74960\" class=\"graphic graphic_picture graphicRef74960 \">picture 20</a>). Grossly, IVT appear as laminated jelly-like to firm lesions from <span class=\"nowrap\">pink/tan</span> to dark red in color, depending upon the age of the thrombus. These lesions are due to fetal hemorrhage into the maternal space and are quite common and usually benign. However, they occur at higher frequency in pregnancies complicated by Rhesus and ABO incompatibilities [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/131-134\" class=\"abstract_t\">131-134</a>] and with maternal diabetes [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/135\" class=\"abstract_t\">135</a>]. Other signs of fetal anemia (eg, circulating immature red blood cells and hydrops) should be present in severe cases of chronic fetomaternal hemorrhage [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/136\" class=\"abstract_t\">136</a>], but are not observed with acute hemorrhage. Three or more IVT or any IVT associated with a stillbirth warrant investigation for fetomaternal hemorrhage. (See <a href=\"topic.htm?path=massive-fetomaternal-hemorrhage#H784295482\" class=\"medical medical_review\">&quot;Massive fetomaternal hemorrhage&quot;, section on 'Laboratory evaluation'</a>.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h4\">Chorangioma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placental neoplasms are generally benign neoplasms such as chorangiomas (<a href=\"image.htm?imageKey=OBGYN%2F67130\" class=\"graphic graphic_picture graphicRef67130 \">picture 21</a>) and vascular neoplasms of the stem villi [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/81,137-146\" class=\"abstract_t\">81,137-146</a>]. Teratomas and other much rarer lesions also may occur [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/147-151\" class=\"abstract_t\">147-151</a>].</p><p>Chorangiomas (also called chorioangiomas) range from microscopic lesion(s) to large masses. Those greater than 4 to 5 cm in diameter carry a risk of fetal morbidity due to high output heart failure from arteriovenous shunting, platelet trapping (consumptive coagulopathy), and preterm delivery [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/146,152\" class=\"abstract_t\">146,152</a>]. Polyhydramnios is also common [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/153\" class=\"abstract_t\">153</a>]. </p><p>Care should be taken in evaluation of the trophoblast associated with chorangiomas. The surface of a chorangioma is covered with villous trophoblast as these lesions are thought to arise in stem villi. Often the villous trophoblast is hyperplastic [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/78,154\" class=\"abstract_t\">78,154</a>], suggesting the diagnosis of an intraplacental choriocarcinoma; however, this diagnosis requires malignant trophoblast and is usually accompanied by necrosis. [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/152\" class=\"abstract_t\">152</a>].</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h4\">Metastatic neoplasms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Metastatic neoplasms can result from any hematogenously spread of malignant neoplasm [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/155-166\" class=\"abstract_t\">155-166</a>]. Grossly, they appear as an infarct-like mass lesion on the maternal side of the placenta. In one review, 72 of 87 metastatic neoplasms involved the placenta only, 10 were metastatic just to the fetus, and 5 affected both the placenta and fetus [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/163\" class=\"abstract_t\">163</a>]. The primary sites consisted of melanoma in 27 cases, breast cancer in 15, <span class=\"nowrap\">leukemia/lymphoma</span> in 15, and lung cancer in 10. Fetal involvement was most common with metastatic melanoma (6 of 27), and 5 of these 6 infants died of the disease. No metastatic breast carcinomas affected the fetus. The author has seen lymphoma, intestinal, and breast cancer with their first presentation as a placental metastasis.</p><p>Fetal malignant neoplasms, such as neuroblastoma, can metastasize to the placenta, as well [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/166,167\" class=\"abstract_t\">166,167</a>]. Benign (non-neoplastic) nevus cells can populate the villi, which is a dramatic microscopic finding of no clinical significance [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/168\" class=\"abstract_t\">168</a>].</p><p class=\"headingAnchor\" id=\"H87585479\"><span class=\"h4\">Choriocarcinoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Choriocarcinoma has been detected on placental examination in otherwise unremarkable pregnancies [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/169,170\" class=\"abstract_t\">169,170</a>]. It typically presents as small mass like lesions grossly resembling infarcts. This is one of the reasons that the author believes that all grossly identified mass-like lesions in the placenta should be sampled for histology. Intraplacental choriocarcinomas (choriocarcinomas in situ) are often clinically silent, but often with widespread metastases and they have been reported to metastasize to the fetus [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/169,171\" class=\"abstract_t\">169,171</a>]. (See <a href=\"topic.htm?path=gestational-trophoblastic-disease-pathology\" class=\"medical medical_review\">&quot;Gestational trophoblastic disease: Pathology&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H32\"><span class=\"h1\">SELECTED DISORDERS OF PERINATAL AND MEDICOLEGAL IMPORTANCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some placental findings are of clinical importance either to the mother or <span class=\"nowrap\">fetus/infant</span>. Many of these findings are significant enough to warrant an immediate phone call from the pathologist to the clinician.</p><p class=\"headingAnchor\" id=\"H33\"><span class=\"h2\">Acute versus chronic stress/insult</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The unstressed or acutely stressed gestation should have normal weight placenta for gestational age. Chronic stress often results in a small placenta (&lt;10th percentile for gestational age) (<a href=\"image.htm?imageKey=OBGYN%2F72177\" class=\"graphic graphic_table graphicRef72177 \">table 1</a>), but may produce a very heavy placenta (&gt;99th percentile) in pregnancies complicated by maternal diabetes [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/5\" class=\"abstract_t\">5</a>] or fetal hydrops. Placental weight should be obtained by trimming the umbilical cord and membranes off the disk. Normative standards for different populations are based on the trimmed placental disk weight. The trimmed placental weight, therefore, is a critical parameter of in-utero well-being.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute stress refers to stress of at least 1, but less than 24, hours duration. Placental pathologic findings include meconium pigmentation (if less than 40 weeks of gestation) and acute villous edema [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/172,173\" class=\"abstract_t\">172,173</a>]. When villous edema is severe, it may impair fetal oxygen delivery, resulting in fetal hypoxia and acidosis. Although some authorities believe that the fetus can release immature red blood cells (nucleated red blood cells) in as short a time as hours [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/172,173\" class=\"abstract_t\">172,173</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic stress refers to stress lasting days to weeks. The best indicator of chronic stress is a placental weight less than the 10th percentile; other findings include maternal or fetal vascular malperfusion such as infarcts, amnion nodosum, erythroblastosis, hydrops placentalis, VSK, avascular villi, and VUE [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/63,174-176\" class=\"abstract_t\">63,174-176</a>]. A heavy placenta associated with chronic stress may be due to chronic villous edema associated with syphilis, erythroblastosis fetalis, or any other cause of fetal hydrops.</p><p/><p class=\"headingAnchor\" id=\"H2951801940\"><span class=\"h2\">Preeclampsia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The parenchymal finding most characteristically associated with preeclampsia is acute atherosis (ie, fibrinoid necrosis of the vessel wall with an accumulation of lipid-laden &ldquo;foamy&rdquo; macrophages and a mononuclear perivascular infiltrate) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/119-124,177-182\" class=\"abstract_t\">119-124,177-182</a>]. Vascular ectasia and thrombi may also be present. The histopathological diagnosis is made by examination of vessels in the decidua parietalis (part of the extraplacental membranes). Other characteristic features of preeclampsia in the placenta include those of maternal vascular malperfusion (MVM):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Distal villous hypoplasia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placental infarcts</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Small placenta by weight</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute or chronic abruption</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decidual arteriopathy, with or without acute atherosis</p><p/><p class=\"headingAnchor\" id=\"H87576122\"><span class=\"h2\">Intrauterine growth restriction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The placenta can show a wide variety of findings in intrauterine growth restriction since this disorder has a wide variety of etiologies (see <a href=\"topic.htm?path=fetal-growth-restriction-evaluation-and-management\" class=\"medical medical_review\">&quot;Fetal growth restriction: Evaluation and management&quot;</a>). Features that have been correlated with idiopathic growth restriction include VUE, FVM, MVM, perivillous fibrin deposition that is excessive and located away from the margin and chorionic plate, extensive stromal fibrosis, and fetoplacental vascular maldevelopment; however, all of these changes may not be present and the magnitude of change may be minor [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/183-185\" class=\"abstract_t\">183-185</a>]. (See <a href=\"#H21\" class=\"local\">'Parenchymal infarcts, syncytial knotting, and other lesions associated with malperfusion'</a> above and <a href=\"#H4507183\" class=\"local\">'Excessive fibrin deposition'</a> above.)</p><p class=\"headingAnchor\" id=\"H87576091\"><span class=\"h2\">Neurologically impaired infant</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Examination of the placenta can provide information regarding the etiology of neurologically impaired infants and children [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/186\" class=\"abstract_t\">186</a>]&nbsp;(see <a href=\"topic.htm?path=placental-pathology-in-cases-of-neurologically-impaired-infants\" class=\"medical medical_review\">&quot;Placental pathology in cases of neurologically impaired infants&quot;</a>).</p><p class=\"headingAnchor\" id=\"H37\"><span class=\"h2\">Recurrent preterm birth</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A study of placental histology in recurrent preterm birth reported neutrophilic inflammation of the membranes, chorionic plate, and umbilical cord in 50 percent or more of pregnancies with recurrent spontaneous preterm birth [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/187\" class=\"abstract_t\">187</a>]. Inflammation leading to thromboses in chorionic and umbilical vessels was not uncommon, possibly due to activation of the clotting cascade as a result of infection. The thrombosis began in the intima of chorionic veins and umbilical vessels, ultimately resulting in villous atrophy. Of note, this is an uncommon cause of thromboses of large placental veins, which is usually secondary to obstruction to venous return.</p><p>Other pathologies that recur and are often associated with preterm birth include <span class=\"nowrap\">MFI/MPFD</span> and abruption. (See <a href=\"#H4507189\" class=\"local\">'Maternal floor infarction/massive perivillous fibrin deposition'</a> above and <a href=\"#H4506339\" class=\"local\">'Abruptio placenta'</a> below.)</p><p class=\"headingAnchor\" id=\"H38\"><span class=\"h2\">Multiple gestation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placental examination in multifetal gestation helps to determine zygosity, but may not be conclusive [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/188-190\" class=\"abstract_t\">188-190</a>]. (See <a href=\"topic.htm?path=twin-pregnancy-labor-and-delivery#H1584080997\" class=\"medical medical_review\">&quot;Twin pregnancy: Labor and delivery&quot;, section on 'Monozygotic or dizygotic?'</a>.)</p><p class=\"headingAnchor\" id=\"H4506339\"><span class=\"h2\">Abruptio placenta</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In general, the diagnosis of acute abruptio placenta is made clinically. Histological findings, such as diffuse retromembranous <span class=\"nowrap\">and/or</span> intradecidual hemorrhages, irregular basal intervillous thrombi (IVT), and recent villous stromal hemorrhage, are not specific for the diagnosis and may rarely occur with normal placental detachment at delivery [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/191\" class=\"abstract_t\">191</a>]. In some cases, intravillous hemorrhage (<a href=\"image.htm?imageKey=OBGYN%2F94965\" class=\"graphic graphic_picture graphicRef94965 \">picture 22</a>) can be identified in acute abruption due to rupture of the villous capillaries resulting in free blood in the intravillous stroma; however, intravillous hemorrhage is a non-specific finding. An organizing retroplacental hematoma with overlying recent villous infarction is another pathologic finding in subacute to chronic abruption. Recent infarcts are characterized by preservation of villous stromal architecture, eosinophilic degeneration of the syncytiotrophoblast, and villous agglutination with scattered intervillous neutrophils. These infarcts take many hours to develop. </p><p>Several risk factors have been associated with abruption; history of a previous abruption confers the highest risk. However, most abruptions are idiopathic. (See <a href=\"topic.htm?path=placental-abruption-clinical-features-and-diagnosis#H9294247\" class=\"medical medical_review\">&quot;Placental abruption: Clinical features and diagnosis&quot;, section on 'Risk factors'</a>.).</p><p class=\"headingAnchor\" id=\"H87575936\"><span class=\"h2\">Inborn errors of metabolism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Storage material may accumulate in vacuolated placental cells in fetuses with inborn errors of metabolism [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/192\" class=\"abstract_t\">192</a>]. The location and type of inclusion varies depending on the disease. Diagnosis at placental examination will allow for early intervention and reproductive counseling.</p><p class=\"headingAnchor\" id=\"H87576253\"><span class=\"h2\">Chorioamnionitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neutrophilic inflammation of the chorion laeve and amnion (ie, acute chorioamnionitis) is the most frequent histopathological result of ascending transcervical infection and occurs with both symptomatic and silent infections (<a href=\"image.htm?imageKey=OBGYN%2F56454\" class=\"graphic graphic_picture graphicRef56454 \">picture 23</a> and <a href=\"image.htm?imageKey=OBGYN%2F77902\" class=\"graphic graphic_picture graphicRef77902 \">picture 24</a> and <a href=\"image.htm?imageKey=OBGYN%2F50692\" class=\"graphic graphic_picture graphicRef50692 \">picture 25</a> and <a href=\"image.htm?imageKey=OBGYN%2F51447\" class=\"graphic graphic_picture graphicRef51447 \">picture 26</a>) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/193\" class=\"abstract_t\">193</a>]. Isolated chorioamnionitis is characteristic of ascending infection while a hematogenous source displays greater inflammation of the villi (ie, villitis) and intervillous space (ie, intervillositis).</p><p>In one study of 1252 placentas from a high-risk population, histologic evidence of chorioamnionitis was found in 40 percent of patients with clinically apparent infection at delivery and in 15 percent of asymptomatic individuals [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/194\" class=\"abstract_t\">194</a>]. Chorioamnionitis was diagnosed in 6 percent of 43,940 deliveries evaluated in the Collaborative Perinatal Project (CPP) [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/195\" class=\"abstract_t\">195</a>]. The rate increased with decreasing gestational age: 15 percent at 28 to 32 weeks; 8 percent at 33 to 36 weeks; and 5 percent after 36 weeks of gestation. Similarly, another series describing the histopathology of 3928 placentas from pregnancies at 20 to 34 weeks of gestation found histologic chorioamnionitis in 31 percent [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/196\" class=\"abstract_t\">196</a>]. The prevalence fell from 50 to 65 percent before 28 weeks to 16 percent at 34 weeks.</p><p>These studies are from high-risk pregnancies and used broad diagnostic criteria for the diagnosis of chorioamnionitis. The criteria for diagnosing histologic chorioamnionitis vary among pathologists [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/15,197\" class=\"abstract_t\">15,197</a>]. Some definitions involve the number of tissues affected; other definitions have thresholds for the number of neutrophils observed. In the author&rsquo;s opinion, preterm neutrophilic chorioamnionitis is usually due to an acute infection. However, determining the duration of amniotic fluid infection by the severity of the histopathologic findings has proved unreliable [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/58,172\" class=\"abstract_t\">58,172</a>]. Chorioamnionitis at term may be due to other factors including non-infectious entities (for example, epidural anesthesia [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/198\" class=\"abstract_t\">198</a>]), and may be mediated by cytokines [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/193,199-202\" class=\"abstract_t\">193,199-202</a>].</p><p>Chorioamnionitis can be either neutrophilic (frequently called acute) or lympho-histocytic (chronic); neutrophilic chorioamnionitis is more common than lymphohistiocytic chorioamnionitis. Neutrophilic chorioamnionitis is usually mediated by bacteria, while lympho-histiocytic chorioamnionitis can be due to an abnormal immune reaction, a viral or protozoal infection, or, in most cases, an unknown etiology [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/43,44\" class=\"abstract_t\">43,44</a>]. &ldquo;Acute&rdquo; chorioamnionitis is associated with an inflammatory infiltrate typically consisting of neutrophils or a mixture of neutrophils and mononuclear cells; eosinophils also may be present. The infiltrate involves one or more of the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chorionic plate</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Amnion of the placental membranes</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fetal surface of the placental disk</p><p/><p>An additional feature may include inflammatory infiltrate of the vascular portion of the umbilical cord or Wharton's jelly. There is a 70 to 90 percent correlation between the presence of leukocytes in the fetal membranes and associated placental and funic inflammation [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/203\" class=\"abstract_t\">203</a>]. Fetal membranes also occasionally contain a large number of eosinophils; these are likely to be fetal inflammatory cells.</p><p>Inflammatory infiltrates in the maternal decidua and confined to the chorionic epithelium can be normal. Decidua usually has an inflammatory infiltrate, typically neutrophilic or mixed <span class=\"nowrap\">neutrophilic/lymphocytic,</span> during all stages of gestation and labor may induce inflammatory cell migration into the chorion. In contrast, plasma cells are <strong>not</strong> normally present and should be considered pathologic. Inflammatory cells in the villi are also pathologic.</p><p>The clinical diagnosis of infection is not always confirmed by histologic or microbiologic studies. In one study of 139 pregnancies with clinical findings of presumed infection, histologic examination of the placenta did not support the clinical diagnosis in approximately one-third of cases [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/204\" class=\"abstract_t\">204</a>]. The investigators suggested that noninflammatory events (eg, epidural anesthesia, abruption) could be responsible for maternal fever, tachycardia, uterine tenderness, or malodorous amniotic fluid. The author believes that clinically significant chorioamnionitis diagnosed histopathologically should be reserved for those cases with significant inflammation: diffuse or multifocal involvement of the membranes <span class=\"nowrap\">and/or</span> chorionic plate with large numbers of inflammatory cells present. Minute foci of &lt;10 neutrophils in the membranes should be ignored.</p><p>Conversely, histologic evidence of placental inflammation may not always be associated with microbiologic evidence of an infectious organism. Cultures of the amniotic fluid or membranes do not document a bacterial infection in 25 to 30 percent of placentas with histologic chorioamnionitis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/198,203\" class=\"abstract_t\">198,203</a>]. Negative cultures in the presence of histologic inflammation may be due to suboptimal microbiologic techniques for fastidious organisms such as Mycoplasma sp., administration of intrapartum antibiotics, or a noninfectious process.</p><p class=\"headingAnchor\" id=\"H87579796\"><span class=\"h3\">Candida</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intrauterine candidal infections are rare. Unlike most ascending infections, intrauterine candidiasis often occurs without rupture of the fetal membranes. The specific maternal risk factors associated with intrauterine candidal infection include diabetes mellitus, sickle cell disease, presence of a cerclage, retained intrauterine contraceptive device, and immunocompromise.</p><p>Severe funisitis (ie, inflammation of the umbilical cord) and neutrophilic chorioamnionitis without villitis are the hallmarks of candidal infection. Grossly, the classic finding is multiple small green <span class=\"nowrap\">and/or</span> white abscesses on the surface of the umbilical cord. Microscopically, microabscesses with hyphae are usually present only on the cord's surface, but invasion into Wharton's jelly can occur (<a href=\"image.htm?imageKey=OBGYN%2F58878%7EOBGYN%2F74230\" class=\"graphic graphic_picture graphicRef58878 graphicRef74230 \">picture 27A-B</a>). The presence of invasive hyphae in the cord is a risk factor for hematogenous dissemination to the fetus, in whom infection is rare and often catastrophic. Fungal organisms may be observed with routine or special stains.</p><p class=\"headingAnchor\" id=\"H87579823\"><span class=\"h3\">Fusobacterium</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This gram negative anaerobe has a strong association with neutrophilic chorioamnionitis and appears to play a role in the pathogenesis of spontaneous preterm birth, but is not a cause of neonatal sepsis [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/205,206\" class=\"abstract_t\">205,206</a>]. Histopathology shows a severe, typically necrotizing, infiltrate (<a href=\"image.htm?imageKey=OBGYN%2F53331\" class=\"graphic graphic_picture graphicRef53331 \">picture 28</a>). Long filamentous fusiform bacilli can be readily identified with standard hematoxylin-eosin or bacterial stains.</p><p class=\"headingAnchor\" id=\"H87583059\"><span class=\"h3\">Mycoplasma hominis and Ureaplasma urealyticum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common organisms identified in acute chorioamnionitis are mycoplasmas (<em>Ureaplasma urealysticum</em> [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/207\" class=\"abstract_t\">207</a>]<em> </em>and <em>Mycoplasma hominis </em>[<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/208\" class=\"abstract_t\">208</a>]). They often present with a high stage and grade maternal and fetal inflammatory response. </p><p class=\"headingAnchor\" id=\"H87581300\"><span class=\"h2\">Streptococcal infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are no specific placental histopathologic features of group B streptococcus (GBS) infection. Funisitis accompanies up to one-third of cases with neutrophilic chorioamnionitis. However, histopathology often does not show chorioamnionitis, despite well-documented cases of neonatal infection [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/209\" class=\"abstract_t\">209</a>]. This may be due to the virulence of even short-term fetal exposure to GBS.</p><p>Group A streptococcus (GAS) can cause fulminant maternal infection and death [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/210\" class=\"abstract_t\">210</a>]. GAS appears to invade the myometrium as a result of bacteremia associated with nongenital tract infection (eg, upper respiratory tract). The predominant histopathologic feature is neutrophilic purulent myometritis.</p><p class=\"headingAnchor\" id=\"H39\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>All placentas should undergo a basic examination including color, length of umbilical cord, number of cord vessels and weight of the trimmed placental disk. Complete gross and histopathologic examination of the placenta should be obtained when clinically indicated by adverse maternal, fetal, or neonatal outcome. (See <a href=\"#H13522917\" class=\"local\">'Indications for placental pathology examination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Placental pathology provides information that (1) helps to explain complications that occurred during the pregnancy, (2) should prompt immediate intervention (eg, previously unrecognized infection), <span class=\"nowrap\">and/or</span> (3) is predictive of future maternal or offspring problems. (See <a href=\"#H63689380\" class=\"local\">'The placental pathology report'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The weight and maturational level of the placenta correlate with the functionality of the placenta. Standards for placental weights at different gestational ages are available. Villous maturation should also be appropriate for gestational age. Identification of mature villi in a preterm gestation (ie, before 32 weeks) suggests placental ischemia. Identification of immature villi late in gestation (ie, at term) suggests the placenta was less efficient in gas and nutrient exchange. (See <a href=\"#H2761470833\" class=\"local\">'Maturity'</a> above and <a href=\"#H665901411\" class=\"local\">'Weight'</a> above.)</p><p/><p>Standardized reporting is helpful for the clinician and should be followed [<a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Common specific diagnoses and their clinical associations include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Funisitis</strong> involving only the external surface of the cord and Wharton's jelly is most likely of maternal origin. Inflammatory cells seen migrating out through the fetal vessels in the cord are evidence of a fetal response and are diagnostic of systemic fetal inflammatory response syndrome. (See <a href=\"#H4\" class=\"local\">'Inflammation'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong><span class=\"nowrap\">Acute/neutrophilic</span> chorioamnionitis</strong> is usually bacteria-mediated and is the most common pathologic finding in placental examination. <span class=\"nowrap\">Chronic/mononuclear</span> chorioamnionitis is characterized by a mononuclear cell infiltrate (ie, lymphocytes, histiocytes, and plasma cells) and often has a noninfectious etiology. (See <a href=\"#H9\" class=\"local\">'Acute or chronic chorioamnionitis'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Meconium</strong> may induce umbilical cord vascular necrosis, amniotic epithelial necrosis, myocyte necrosis, and a fetal inflammatory response. (See <a href=\"#H5\" class=\"local\">'Meconium staining'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Neutrophilic and lympho-histiocytic (&quot;acute&quot; and &quot;chronic&quot;)</strong> <strong>villitis</strong> are inflammatory infiltrates involving the placental parenchyma, but are due to different etiologies. The specific diagnosis is based upon the nature and type of inflammatory infiltrate. Villitis of unknown etiology (VUE) is the most common chronic villitis and has a small recurrence risk. Villitis, when diffuse or present in a small placenta, is a cause of fetal growth restriction and death. Focal chronic villitis is common and of no clinical significance. (See <a href=\"#H18\" class=\"local\">'Villitis'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Peripheral <strong>infarcts</strong> usually on the maternal side of the placenta at the margin are common at term and usually not clinically significant. Perinatal morbidity is associated with infarcts of more than 5 percent of the placental mass or greater than 3 cm in diameter. Preterm placentas with infarcts are very rare and usually these placentas have other features of maternal vascular malperfusion. Infarcts are considered clinically severe (eg, associated with intrauterine growth <span class=\"nowrap\">restriction/stillbirths)</span> if 20 percent or more of the placenta is affected. (See <a href=\"#H21\" class=\"local\">'Parenchymal infarcts, syncytial knotting, and other lesions associated with malperfusion'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Investigation for fetomaternal hemorrhage is suggested if three or more <strong>intervillous thrombi</strong> (IVT) are present or if an intervillous thrombus is associated with a stillbirth. (See <a href=\"#H25\" class=\"local\">'Intervillous thrombi'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Severe diffuse acute villous edema</strong> is a marker of acute fetal stress and is associated with fetal hypoxia. (See <a href=\"#H33\" class=\"local\">'Acute versus chronic stress/insult'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/1\" class=\"nounderline abstract_t\">Langston C, Kaplan C, Macpherson T, et al. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1997; 121:449.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/2\" class=\"nounderline abstract_t\">Gersell DJ. ASCP survey on placental examination. American Society of Clinical Pathologists. Am J Clin Pathol 1998; 109:127.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/3\" class=\"nounderline abstract_t\">Spencer MK, Khong TY. Conformity to guidelines for pathologic examination of the placenta. Arch Pathol Lab Med 2003; 127:205.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/4\" class=\"nounderline abstract_t\">Kraus FT. Perinatal pathology, the placenta, and litigation. Hum Pathol 2003; 34:517.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/5\" class=\"nounderline abstract_t\">Huynh J, Dawson D, Roberts D, Bentley-Lewis R. A systematic review of placental pathology in maternal diabetes mellitus. Placenta 2015; 36:101.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/6\" class=\"nounderline abstract_t\">Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med 2016.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/7\" class=\"nounderline abstract_t\">Higgins M, McAuliffe FM, Mooney EE. Clinical associations with a placental diagnosis of delayed villous maturation: a retrospective study. Pediatr Dev Pathol 2011; 14:273.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/8\" class=\"nounderline abstract_t\">Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007; 50:137.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/9\" class=\"nounderline abstract_t\">Al-Adnani M, Marnerides A, George S, et al. &quot;Delayed Villous Maturation&quot; in Placental Reporting: Concordance among Consultant Pediatric Pathologists at a Single Specialist Center. Pediatr Dev Pathol 2015; 18:375.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/10\" class=\"nounderline abstract_t\">Serra AE, Lemon LS, Mokhtari NB, et al. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study. Am J Obstet Gynecol 2017; 216:418.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/11\" class=\"nounderline abstract_t\">Ernst LM, Minturn L, Huang MH, et al. Gross patterns of umbilical cord coiling: correlations with placental histology and stillbirth. Placenta 2013; 34:583.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/12\" class=\"nounderline abstract_t\">Jessop FA, Lees CC, Pathak S, et al. Umbilical cord coiling: clinical outcomes in an unselected population and systematic review. Virchows Arch 2014; 464:105.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/13\" class=\"nounderline abstract_t\">Patil NS, Kulkarni SR, Lohitashwa R. Umbilical cord coiling index and perinatal outcome. J Clin Diagn Res 2013; 7:1675.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/14\" class=\"nounderline abstract_t\">Qureshi F, Jacques SM, Bendon RW, et al. Candida funisitis: A clinicopathologic study of 32 cases. Pediatr Dev Pathol 1998; 1:118.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/15\" class=\"nounderline abstract_t\">Redline RW, Faye-Petersen O, Heller D, et al. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6:435.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/16\" class=\"nounderline abstract_t\">Redline RW. Placental pathology and cerebral palsy. Clin Perinatol 2006; 33:503.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/17\" class=\"nounderline abstract_t\">Leviton A, Allred EN, Kuban KC, et al. Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. the ELGAN study. Pediatr Res 2010; 67:95.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/18\" class=\"nounderline abstract_t\">Altshuler G, Arizawa M, Molnar-Nadasdy G. Meconium-induced umbilical cord vascular necrosis and ulceration: a potential link between the placenta and poor pregnancy outcome. Obstet Gynecol 1992; 79:760.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/19\" class=\"nounderline abstract_t\">Altshuler G, Hyde S. Meconium-induced vasocontraction: a potential cause of cerebral and other fetal hypoperfusion and of poor pregnancy outcome. J Child Neurol 1989; 4:137.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/20\" class=\"nounderline abstract_t\">Lewis SH, Gilbert-Barness E. The placenta and its significance in neonatal outcome. Adv Pediatr 1998; 45:223.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/21\" class=\"nounderline abstract_t\">Naeye RL. Can meconium in the amniotic fluid injure the fetal brain? Obstet Gynecol 1995; 86:720.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/22\" class=\"nounderline abstract_t\">Miller PW, Coen RW, Benirschke K. Dating the time interval from meconium passage to birth. Obstet Gynecol 1985; 66:459.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/23\" class=\"nounderline abstract_t\">Kreczy A, Alge A, Menardi G, et al. Teratoma of the umbilical cord. Case report with review of the literature. Arch Pathol Lab Med 1994; 118:934.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/24\" class=\"nounderline abstract_t\">Driscoll SG. Umbilical cord teratoma. Hum Pathol 1985; 16:1178.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/25\" class=\"nounderline abstract_t\">Smith D, Majmudar B. Teratoma of the umbilical cord. Hum Pathol 1985; 16:190.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/26\" class=\"nounderline abstract_t\">Ghidini A, Romero R, Eisen RN, et al. Umbilical cord hemangioma. Prenatal identification and review of the literature. J Ultrasound Med 1990; 9:297.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/27\" class=\"nounderline abstract_t\">Kamitomo M, Sueyoshi K, Matsukita S, et al. Hemangioma of the umbilical cord: stenotic change of the umbilical vessels. Fetal Diagn Ther 1999; 14:328.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/28\" class=\"nounderline abstract_t\">S&oslash;ndergaard G. Hemangioma of the umbilical cord. Acta Obstet Gynecol Scand 1994; 73:434.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/29\" class=\"nounderline abstract_t\">Carvounis EE, Dimmick JE, Wright VJ. Angiomyxoma of umbilical cord. Arch Pathol Lab Med 1978; 102:178.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/30\" class=\"nounderline abstract_t\">Yavner DL, Redline RW. Angiomyxoma of the umbilical cord with massive cystic degeneration of Wharton's jelly. Arch Pathol Lab Med 1989; 113:935.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/31\" class=\"nounderline abstract_t\">Lee MC, Aterman K. An intestinal polyp of the umbilical cord. Am J Dis Child 1968; 116:320.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/32\" class=\"nounderline abstract_t\">Klaritsch P, Haeusler M, Karpf E, et al. Spontaneous intrauterine umbilical artery thrombosis leading to severe fetal growth restriction. Placenta 2008; 29:374.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/33\" class=\"nounderline abstract_t\">Solano S&aacute;nchez SR, Baquera Heredia JJ, Reyes Cuervo H, Buen Abad EI. [Umbilical artery thrombosis. A report of a case and review of the literature]. Ginecol Obstet Mex 2005; 73:332.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/34\" class=\"nounderline abstract_t\">Sato Y, Benirschke K. Umbilical arterial thrombosis with vascular wall necrosis: clinicopathologic findings of 11 cases. Placenta 2006; 27:715.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/35\" class=\"nounderline abstract_t\">Afriat R, Bidat L, Fortier F, et al. [Prenatal diagnosis of spontaneous thrombosis of the umbilical artery during the third trimester of pregnancy. Two cases with surviving infants]. J Gynecol Obstet Biol Reprod (Paris) 1995; 24:411.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/36\" class=\"nounderline abstract_t\">Heifetz SA. Thrombosis of the umbilical cord: analysis of 52 cases and literature review. Pediatr Pathol 1988; 8:37.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/37\" class=\"nounderline abstract_t\">Ariel I, Anteby E, Hamani Y, Redline RW. Placental pathology in fetal thrombophilia. Hum Pathol 2004; 35:729.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/38\" class=\"nounderline abstract_t\">Jauniaux E, De Munter C, Vanesse M, et al. Embryonic remnants of the umbilical cord: morphologic and clinical aspects. Hum Pathol 1989; 20:458.</a></li><li class=\"breakAll\">Wigglesworth JS, Singer DB. Textbook of fetal and perinatal pathology, 2nd ed, Wigglesworth JS, Singer DB (Eds), Blackwell Science, 1998.</li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/40\" class=\"nounderline abstract_t\">Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993; 36:795.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/41\" class=\"nounderline abstract_t\">Quinn PA, Butany J, Taylor J, Hannah W. Chorioamnionitis: its association with pregnancy outcome and microbial infection. Am J Obstet Gynecol 1987; 156:379.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/42\" class=\"nounderline abstract_t\">Zhang JM, Kraus FT, Aquino TI. Chorioamnionitis: a comparative histologic, bacteriologic, and clinical study. Int J Gynecol Pathol 1985; 4:1.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/43\" class=\"nounderline abstract_t\">Gersell DJ. Chronic villitis, chronic chorioamnionitis, and maternal floor infarction. Semin Diagn Pathol 1993; 10:251.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/44\" class=\"nounderline abstract_t\">Jacques SM, Qureshi F. Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol 1998; 29:1457.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/45\" class=\"nounderline abstract_t\">Mazor M, Furman B, Wiznitzer A, et al. Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid. Obstet Gynecol 1995; 86:830.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/46\" class=\"nounderline abstract_t\">Altshuler G, Hyde SR. Clinicopathologic implications of placental pathology. Clin Obstet Gynecol 1996; 39:549.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/47\" class=\"nounderline abstract_t\">Altshuler G. Role of the placenta in perinatal pathology (revisited). Pediatr Pathol Lab Med 1996; 16:207.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/48\" class=\"nounderline abstract_t\">Mayer DC, Chescheir NC, Spielman FJ. Increased intrapartum antibiotic administration associated with epidural analgesia in labor. Am J Perinatol 1997; 14:83.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/49\" class=\"nounderline abstract_t\">Simon C, Schr&ouml;der H, Weisner D, et al. Bacteriological findings after premature rupture of the membranes. Arch Gynecol Obstet 1989; 244:69.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/50\" class=\"nounderline abstract_t\">Stevens NG, Sander CH. Placental hemorrhagic endovasculitis: risk factors and impact on pregnancy outcome. Int J Gynaecol Obstet 1984; 22:393.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/51\" class=\"nounderline abstract_t\">Ohyama M, Itani Y, Yamanaka M, et al. Maternal, neonatal, and placental features associated with diffuse chorioamniotic hemosiderosis, with special reference to neonatal morbidity and mortality. Pediatrics 2004; 113:800.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/52\" class=\"nounderline abstract_t\">Redline RW, Wilson-Costello D. Chronic peripheral separation of placenta. The significance of diffuse chorioamnionic hemosiderosis. Am J Clin Pathol 1999; 111:804.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/53\" class=\"nounderline abstract_t\">Roescher AM, Timmer A, Erwich JJ, Bos AF. Placental pathology, perinatal death, neonatal outcome, and neurological development: a systematic review. PLoS One 2014; 9:e89419.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/54\" class=\"nounderline abstract_t\">Redline RW, O'Riordan MA. Placental lesions associated with cerebral palsy and neurologic impairment following term birth. Arch Pathol Lab Med 2000; 124:1785.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/55\" class=\"nounderline abstract_t\">Brown DL, DiSalvo DN, Frates MC, et al. Placental surface cysts detected on sonography: histologic and clinical correlation. J Ultrasound Med 2002; 21:641.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/56\" class=\"nounderline abstract_t\">Boulis TS, Rochelson BL, Williamson AK. Massive Subchorionic Placental Cyst and Poor Fetal Growth: A Case Report. J Reprod Med 2015; 60:458.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/57\" class=\"nounderline abstract_t\">Alanjari A, Wright E, Keating S, et al. Prenatal diagnosis, clinical outcomes, and associated pathology in pregnancies complicated by massive subchorionic thrombohematoma (Breus' mole). Prenat Diagn 2013; 33:973.</a></li><li class=\"breakAll\">Benirschke K, Kaufman P, Baergen RN. The pathology of the human placenta, Springer-Verlag, New York 2006.</li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/59\" class=\"nounderline abstract_t\">Grafe MR, Benirschke K. Ultrastructural study of the amniotic epithelium in a case of gastroschisis. Pediatr Pathol 1990; 10:95.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/60\" class=\"nounderline abstract_t\">Pawoo N, Heller DS. Placental mesenchymal dysplasia. Arch Pathol Lab Med 2014; 138:1247.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/61\" class=\"nounderline abstract_t\">Boog G. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol 2008; 136:9.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/62\" class=\"nounderline abstract_t\">Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007; 38:1439.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/63\" class=\"nounderline abstract_t\">Harteman JC, Nikkels PG, Benders MJ, et al. Placental pathology in full-term infants with hypoxic-ischemic neonatal encephalopathy and association with magnetic resonance imaging pattern of brain injury. J Pediatr 2013; 163:968.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/64\" class=\"nounderline abstract_t\">Nowak C, Joubert M, Jossic F, et al. Perinatal prognosis of pregnancies complicated by placental chronic villitis or intervillositis of unknown etiology and combined lesions: About a series of 178 cases. Placenta 2016; 44:104.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/65\" class=\"nounderline abstract_t\">Althsuler G. Placental villitis of unknown etiology: harbinger of serious disease? A four month's experience of nine cases. J Reprod Med 1973; 11:215.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/66\" class=\"nounderline abstract_t\">Redline RW, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 1993; 143:473.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/67\" class=\"nounderline abstract_t\">Labarrere C, Althabe O. Chronic villitis of unknown aetiology in recurrent intrauterine fetal growth retardation. Placenta 1987; 8:167.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/68\" class=\"nounderline abstract_t\">Becroft DM, Thompson JM, Mitchell EA. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 2005; 192:264.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/69\" class=\"nounderline abstract_t\">Heyborne KD, McGregor JA, Henry G, et al. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994; 171:55.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/70\" class=\"nounderline abstract_t\">Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 2005; 192:452.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/71\" class=\"nounderline abstract_t\">Althaus J, Weir EG, Askin F, et al. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. Am J Obstet Gynecol 2005; 193:1100.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/72\" class=\"nounderline abstract_t\">Russell P, Atkinson K, Krishnan L. Recurrent reproductive failure due to severe placental villitis of unknown etiology. J Reprod Med 1980; 24:93.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/73\" class=\"nounderline abstract_t\">Chen A, Roberts DJ. Placental pathologic lesions with a significant recurrence risk - what not to miss! APMIS 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/74\" class=\"nounderline abstract_t\">Nakamura Y, Sakuma S, Ohta Y, et al. Detection of the human cytomegalovirus gene in placental chronic villitis by polymerase chain reaction. Hum Pathol 1994; 25:815.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/75\" class=\"nounderline abstract_t\">Popek EJ. Granulomatous villitis due to Toxoplasma gondii. Pediatr Pathol 1992; 12:281.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/76\" class=\"nounderline abstract_t\">Redline RW. Recurrent villitis of bacterial etiology. Pediatr Pathol Lab Med 1996; 16:995.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/77\" class=\"nounderline abstract_t\">Altshuler G. Chorangiosis. An important placental sign of neonatal morbidity and mortality. Arch Pathol Lab Med 1984; 108:71.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/78\" class=\"nounderline abstract_t\">Ogino S, Redline RW. Villous capillary lesions of the placenta: distinctions between chorangioma, chorangiomatosis, and chorangiosis. Hum Pathol 2000; 31:945.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/79\" class=\"nounderline abstract_t\">Bentley-Lewis R, Dawson DL, Wenger JB, et al. Placental histomorphometry in gestational diabetes mellitus: the relationship between subsequent type 2 diabetes mellitus and race/ethnicity. Am J Clin Pathol 2014; 141:587.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/80\" class=\"nounderline abstract_t\">Gupta R, Nigam S, Arora P, et al. Clinico-pathological profile of 12 cases of chorangiosis. Arch Gynecol Obstet 2006; 274:50.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/81\" class=\"nounderline abstract_t\">Benirschke K. Recent trends in chorangiomas, especially those of multiple and recurrent chorangiomas. Pediatr Dev Pathol 1999; 2:264.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/82\" class=\"nounderline abstract_t\">Benirschke K. Placenta pathology questions to the perinatologist. J Perinatol 1994; 14:371.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/83\" class=\"nounderline abstract_t\">Benirschke K. Obstetrically important lesions of the umbilical cord. J Reprod Med 1994; 39:262.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/84\" class=\"nounderline abstract_t\">Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002; 5:159.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/85\" class=\"nounderline abstract_t\">Adams-Chapman I, Vaucher YE, Bejar RF, et al. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol 2002; 22:236.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/86\" class=\"nounderline abstract_t\">Devisme L, Chauvi&egrave;re C, Franquet-Ansart H, et al. Perinatal outcome of placental massive perivillous fibrin deposition: a case-control study. Prenat Diagn 2017; 37:323.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/87\" class=\"nounderline abstract_t\">Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med 1996; 16:293.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/88\" class=\"nounderline abstract_t\">Mandsager NT, Bendon R, Mostello D, et al. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol 1994; 83:750.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/89\" class=\"nounderline abstract_t\">Nickel RE. Maternal floor infarction: an unusual cause of intrauterine growth retardation. Am J Dis Child 1988; 142:1270.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/90\" class=\"nounderline abstract_t\">Naeye RL. Maternal floor infarction. Hum Pathol 1985; 16:823.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/91\" class=\"nounderline abstract_t\">Clewell WH, Manchester DK. Recurrent maternal floor infarction: a preventable cause of fetal death. Am J Obstet Gynecol 1983; 147:346.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/92\" class=\"nounderline abstract_t\">Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002; 109:570.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/93\" class=\"nounderline abstract_t\">Doss BJ, Greene MF, Hill J, et al. Massive chronic intervillositis associated with recurrent abortions. Hum Pathol 1995; 26:1245.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/94\" class=\"nounderline abstract_t\">Jacques SM, Qureshi F. Chronic intervillositis of the placenta. Arch Pathol Lab Med 1993; 117:1032.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/95\" class=\"nounderline abstract_t\">Fuke Y, Aono T, Imai S, et al. Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation. Gynecol Obstet Invest 1994; 38:5.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/96\" class=\"nounderline abstract_t\">Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998; 22:1006.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/97\" class=\"nounderline abstract_t\">Martines RB, Bhatnagar J, de Oliveira Ramos AM, et al. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet 2016; 388:898.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/98\" class=\"nounderline abstract_t\">Martines RB, Bhatnagar J, Keating MK, et al. Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses--Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:159.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/99\" class=\"nounderline abstract_t\">Ribeiro CF, Silami VG, Brasil P, Nogueira RM. Sickle-cell erythrocytes in the placentas of dengue-infected women. Int J Infect Dis 2012; 16:e72.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/100\" class=\"nounderline abstract_t\">Hyde SR, Benirschke K. Gestational psittacosis: case report and literature review. Mod Pathol 1997; 10:602.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/101\" class=\"nounderline abstract_t\">Redline RW, Boyd T, Campbell V, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7:237.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/102\" class=\"nounderline abstract_t\">Cetin I, Foidart JM, Miozzo M, et al. Fetal growth restriction: a workshop report. Placenta 2004; 25:753.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/103\" class=\"nounderline abstract_t\">Chaddha V, Viero S, Huppertz B, Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med 2004; 9:357.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/104\" class=\"nounderline abstract_t\">Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000; 92:35.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/105\" class=\"nounderline abstract_t\">Fox H. Pathology of the placenta. Clin Obstet Gynaecol 1986; 13:501.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/106\" class=\"nounderline abstract_t\">Rayburn W, Sander C, Compton A. Histologic examination of the placenta in the growth-retarded fetus. Am J Perinatol 1989; 6:58.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/107\" class=\"nounderline abstract_t\">Rodriguez JG, Porter HJ, Andrews HS, Soothill PW. Placental lesions: is growth a predictor of bad outcome? Fetal Diagn Ther 1997; 12:163.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/108\" class=\"nounderline abstract_t\">Salafia CM, Minior VK, Pezzullo JC, et al. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol 1995; 173:1049.</a></li><li class=\"breakAll\">Fox H. The pathology of the placenta, 2nd ed, WB Saunders Co, Philadelphia 1997.</li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/110\" class=\"nounderline abstract_t\">Naeye RL. Placental infarction leading to fetal or neonatal death. A prospective study. Obstet Gynecol 1977; 50:583.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/111\" class=\"nounderline abstract_t\">Tettey Y, Wiredu EK. Autopsy studies on still births in Korle Bu Teaching Hospital: pathological findings in still births and their placentae. West Afr J Med 1997; 16:12.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/112\" class=\"nounderline abstract_t\">Corr&ecirc;a RR, Gilio DB, Cavellani CL, et al. Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet 2008; 277:201.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/113\" class=\"nounderline abstract_t\">Vinnars MT, Wijnaendts LC, Westgren M, et al. Severe preeclampsia with and without HELLP differ with regard to placental pathology. Hypertension 2008; 51:1295.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/114\" class=\"nounderline abstract_t\">Zhang P, Schmidt M, Cook L. Maternal vasculopathy and histologic diagnosis of preeclampsia: poor correlation of histologic changes and clinical manifestation. Am J Obstet Gynecol 2006; 194:1050.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/115\" class=\"nounderline abstract_t\">Ernst LM, Parkash V. Placental pathology in fetal bartter syndrome. Pediatr Dev Pathol 2002; 5:76.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/116\" class=\"nounderline abstract_t\">Maruyama H, Shinno Y, Fujiwara K, et al. Nephrocalcinosis and placental findings in neonatal bartter syndrome. AJP Rep 2013; 3:21.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/117\" class=\"nounderline abstract_t\">Schwartz DA. Viral infection, proliferation, and hyperplasia of Hofbauer cells and absence of inflammation characterize the placental pathology of fetuses with congenital Zika virus infection. Arch Gynecol Obstet 2017; 295:1361.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/118\" class=\"nounderline abstract_t\">Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995; 26:80.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/119\" class=\"nounderline abstract_t\">Rayne SC, Kraus FT. Placental thrombi and other vascular lesions. Classification, morphology, and clinical correlations. Pathol Res Pract 1993; 189:2.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/120\" class=\"nounderline abstract_t\">Redline RW, Wilson-Costello D, Borawski E, et al. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants. Arch Pathol Lab Med 1998; 122:1091.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/121\" class=\"nounderline abstract_t\">Sander CM, Gilliland D, Flynn MA, Swart-Hills LA. Risk factors for recurrence of hemorrhagic endovasculitis of the placenta. Obstet Gynecol 1997; 89:569.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/122\" class=\"nounderline abstract_t\">Sander CH, Stevens NG. Hemorrhagic endovasculitis of the placenta: an indepth morphologic appraisal with initial clinical and epidemiologic observations. Pathol Annu 1984; 19 Pt 1:37.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/123\" class=\"nounderline abstract_t\">Sander CH, Kinnane L, Stevens NG. Hemorrhagic endovasculitis of the placenta: a clinicopathologic entity associated with adverse pregnancy outcome. Compr Ther 1985; 11:66.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/124\" class=\"nounderline abstract_t\">Sander CH, Kinnane L, Stevens NG, Echt R. Haemorrhagic endovasculitis of the placenta: a review with clinical correlation. Placenta 1986; 7:551.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/125\" class=\"nounderline abstract_t\">Vern TZ, Alles AJ, Kowal-Vern A, et al. Frequency of factor V(Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions. Hum Pathol 2000; 31:1036.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/126\" class=\"nounderline abstract_t\">Kraus FT. Placental thrombi and related problems. Semin Diagn Pathol 1993; 10:275.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/127\" class=\"nounderline abstract_t\">Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol 1999; 30:759.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/128\" class=\"nounderline abstract_t\">Iwasenko JM, Howard J, Arbuckle S, et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis 2011; 203:1526.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/129\" class=\"nounderline abstract_t\">Sander CM, Gilliland D, Akers C, et al. Livebirths with placental hemorrhagic endovasculitis: interlesional relationships and perinatal outcomes. Arch Pathol Lab Med 2002; 126:157.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/130\" class=\"nounderline abstract_t\">Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7:443.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/131\" class=\"nounderline abstract_t\">Batcup G, Tovey LA, Longster G. Fetomaternal blood group incompatibility studies in placental intervillous thrombosis. Placenta 1983; 4 Spec No:449.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/132\" class=\"nounderline abstract_t\">Kaplan C, Blanc WA, Elias J. Identification of erythrocytes in intervillous thrombi: a study using immunoperoxidase identification of hemoglobins. Hum Pathol 1982; 13:554.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/133\" class=\"nounderline abstract_t\">Hoogland HJ, de Haan J, Vooys GP. Ultrasonographic diagnosis of intervillous thrombosis related to Rh isoimmunization. Gynecol Obstet Invest 1979; 10:237.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/134\" class=\"nounderline abstract_t\">Rolschau J. Infarctions and intervillous thrombosis in placenta, and their association with intrauterine growth retardation. Acta Obstet Gynecol Scand Suppl 1978; 72:22.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/135\" class=\"nounderline abstract_t\">Basnet KM, Bentley-Lewis R, Wexler DJ, et al. Prevalence of Intervillous Thrombi Is Increased in Placentas from Pregnancies Complicated by Diabetes. Pediatr Dev Pathol 2016; 19:502.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/136\" class=\"nounderline abstract_t\">Biankin SA, Arbuckle SM, Graf NS. Autopsy findings in a series of five cases of fetomaternal haemorrhages. Pathology 2003; 35:319.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/137\" class=\"nounderline abstract_t\">Khalifa MA, Gersell DJ, Hansen CH, Lage JM. Hepatic (hepatocellular) adenoma of the placenta: a study of four cases. Int J Gynecol Pathol 1998; 17:241.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/138\" class=\"nounderline abstract_t\">Soma H, Watanabe Y, Hata T. Chorangiosis and chorangioma in three cohorts of placentas from Nepal, Tibet, and Japan. Reprod Fertil Dev 1995; 7:1533.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/139\" class=\"nounderline abstract_t\">Takayama M, Soma H, Yaguchi S, et al. Abnormally large placenta associated with Beckwith-Wiedemann syndrome. Gynecol Obstet Invest 1986; 22:165.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/140\" class=\"nounderline abstract_t\">Chen CP, Chern SR, Wang TY, et al. Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. Hum Reprod 1997; 12:2553.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/141\" class=\"nounderline abstract_t\">Sabhikhi AK, Chaudhury MC, Singh D, Raja LN. Chorangioma of the placenta with hydrops fetalis. Indian Pediatr 1996; 33:520.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/142\" class=\"nounderline abstract_t\">Majlessi HF, Wagner KM, Brooks JJ. Atypical cellular chorangioma of the placenta. Int J Gynecol Pathol 1983; 1:403.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/143\" class=\"nounderline abstract_t\">Kohler HG, Iqbal N, Jenkins DM. Chorionic haemangiomata and abruptio placentae. Case report and review. Br J Obstet Gynaecol 1976; 83:667.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/144\" class=\"nounderline abstract_t\">Jones CE, Rivers RP, Taghizadeh A. Disseminated intravascular coagulation and fetal hydrops in a newborn infant in association with a chorangioma of placenta. Pediatrics 1972; 50:901.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/145\" class=\"nounderline abstract_t\">Kim CK, Benirschke K, Connolly KS. Chorangioma of the placenta. Chromosomal and electron microscopic studies. Obstet Gynecol 1971; 37:372.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/146\" class=\"nounderline abstract_t\">Sepulveda W, Alcalde JL, Schnapp C, Bravo M. Perinatal outcome after prenatal diagnosis of placental chorioangioma. Obstet Gynecol 2003; 102:1028.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/147\" class=\"nounderline abstract_t\">Elag&ouml;z S, Aker H, Cetin A. Placental teratoma. A case report. Eur J Obstet Gynecol Reprod Biol 1998; 80:263.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/148\" class=\"nounderline abstract_t\">Shimojo H, Itoh N, Shigematsu H, Yamazaki T. Mature teratoma of the placenta. Pathol Int 1996; 46:372.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/149\" class=\"nounderline abstract_t\">Koumantakis E, Makrigiannakis A, Froudarakis G, et al. Teratoma of the placenta. A case report. Clin Exp Obstet Gynecol 1996; 23:268.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/150\" class=\"nounderline abstract_t\">Wang L, Du X, Li M. Placental teratoma. A case report and review of the literature. Pathol Res Pract 1995; 191:1267.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/151\" class=\"nounderline abstract_t\">Jaswal TS, Sen R, Singh S, et al. Teratoma of the placenta. J Indian Med Assoc 1995; 93:362, 345.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/152\" class=\"nounderline abstract_t\">Zanardini C, Papageorghiou A, Bhide A, Thilaganathan B. Giant placental chorioangioma: natural history and pregnancy outcome. Ultrasound Obstet Gynecol 2010; 35:332.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/153\" class=\"nounderline abstract_t\">Wu Z, Hu W. Clinical analysis of 26 patients with histologically proven placental chorioangiomas. Eur J Obstet Gynecol Reprod Biol 2016; 199:156.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/154\" class=\"nounderline abstract_t\">Khong TY. Chorangioma with trophoblastic proliferation. Virchows Arch 2000; 436:167.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/155\" class=\"nounderline abstract_t\">Eltorky M, Khare VK, Osborne P, Shanklin DR. Placental metastasis from maternal carcinoma. A report of three cases. J Reprod Med 1995; 40:399.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/156\" class=\"nounderline abstract_t\">Baergen RN, Johnson D, Moore T, Benirschke K. Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch Pathol Lab Med 1997; 121:508.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/157\" class=\"nounderline abstract_t\">Wang T, Hamann W, Hartge R. Structural aspects of a placenta from a case of maternal acute lymphatic leukaemia. Placenta 1983; 4:185.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/158\" class=\"nounderline abstract_t\">Russell P, Laverty CR. Malignant melanoma metastases in the placenta: a case report. Pathology 1977; 9:251.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/159\" class=\"nounderline abstract_t\">Sokol RJ, Hutchison P, Cowan D, Reed GB. Amelanotic melanoma metastatic to the placenta. Am J Obstet Gynecol 1976; 124:431.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/160\" class=\"nounderline abstract_t\">Potter JF, Schoeneman M. Metastasis of maternal cancer to the placenta and fetus. Cancer 1970; 25:380.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/161\" class=\"nounderline abstract_t\">Tsukamoto N, Kashimura Y, Sano M, et al. Choriocarcinoma occurring within the normal placenta with breast metastasis. Gynecol Oncol 1981; 11:348.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/162\" class=\"nounderline abstract_t\">Choriocarcinoma of the placenta. By the OSMA Committee on Maternal Health. Ohio State Med J 1975; 71:144.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/163\" class=\"nounderline abstract_t\">Alexander A, Samlowski WE, Grossman D, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 2003; 21:2179.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/164\" class=\"nounderline abstract_t\">Altman JF, Lowe L, Redman B, et al. Placental metastasis of maternal melanoma. J Am Acad Dermatol 2003; 49:1150.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/165\" class=\"nounderline abstract_t\">Pavlidis N. Lung cancer during pregnancy: an emerging issue. Lung Cancer 2008; 59:279.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/166\" class=\"nounderline abstract_t\">Sebire NJ, Jauniaux E. Fetal and placental malignancies: prenatal diagnosis and management. Ultrasound Obstet Gynecol 2009; 33:235.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/167\" class=\"nounderline abstract_t\">Anders D, Kindermann G, Pfeifer U. Metastasizing fetal neuroblastoma with involvement of the placenta simulating fetal erythroblastosis. Report of two cases. J Pediatr 1973; 82:50.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/168\" class=\"nounderline abstract_t\">Sotelo-Avila C, Graham M, Hanby DE, Rudolph AJ. Nevus cell aggregates in the placenta. A histochemical and electron microscopic study. Am J Clin Pathol 1988; 89:395.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/169\" class=\"nounderline abstract_t\">Lage JM, Roberts DJ. Choriocarcinoma in a term placenta: pathologic diagnosis of tumor in an asymptomatic patient with metastatic disease. Int J Gynecol Pathol 1993; 12:80.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/170\" class=\"nounderline abstract_t\">Roberts DJ, Mutter GL. Advances in the molecular biology of gestational trophoblastic disease. J Reprod Med 1994; 39:201.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/171\" class=\"nounderline abstract_t\">Mosher R, Genest DR. Primary intraplacental choriocarcinoma: Clinical and pathologic features of seven cases (1967-1996) and discussion of the differential. Journal of Surgical Pathology 1997; 2:83.</a></li><li class=\"breakAll\">Fox H. Pathology of the Placenta. In: Major Problems in Pathology, 2nd ed, WB Saunders Co, London 1997. p.488.</li><li class=\"breakAll\">Benirschke K, Kaufman P. The pathology of the human placenta, 3rd ed, Springer-Verlag, New York 1995.</li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/174\" class=\"nounderline abstract_t\">Khong TY. From delivery suite to laboratory: optimizing returns from placental examination in medico-legal defence. Aust N Z J Obstet Gynaecol 1997; 37:1.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/175\" class=\"nounderline abstract_t\">Altshuler G. Placenta within the medicolegal imperative. Arch Pathol Lab Med 1991; 115:688.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/176\" class=\"nounderline abstract_t\">Benirschke K. The placenta in the litigation process. Am J Obstet Gynecol 1990; 162:1445.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/177\" class=\"nounderline abstract_t\">Khong TY. Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus. Arch Pathol Lab Med 1991; 115:722.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/178\" class=\"nounderline abstract_t\">Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98:648.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/179\" class=\"nounderline abstract_t\">Khong TY, Pearce JM, Robertson WB. Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion. Am J Obstet Gynecol 1987; 157:360.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/180\" class=\"nounderline abstract_t\">Davies BR. Decidual vascular lesions of fibrinoid necrosis/atherosis. Am J Obstet Gynecol 1982; 144:118.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/181\" class=\"nounderline abstract_t\">Soma H, Yoshida K, Mukaida T, Tabuchi Y. Morphologic changes in the hypertensive placenta. Contrib Gynecol Obstet 1982; 9:58.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/182\" class=\"nounderline abstract_t\">Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens 1976; 5:115.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/183\" class=\"nounderline abstract_t\">Salafia CM, Vintzileos AM, Silberman L, et al. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol 1992; 9:179.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/184\" class=\"nounderline abstract_t\">Todros T, Sciarrone A, Piccoli E, et al. Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet Gynecol 1999; 93:499.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/185\" class=\"nounderline abstract_t\">Krebs C, Macara LM, Leiser R, et al. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1996; 175:1534.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/186\" class=\"nounderline abstract_t\">Anderson GM, Jacobs-Stannard A, Chawarska K, et al. Placental trophoblast inclusions in autism spectrum disorder. Biol Psychiatry 2007; 61:487.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/187\" class=\"nounderline abstract_t\">Goldenberg RL, Andrews WW, Faye-Petersen O, et al. The Alabama Preterm Birth Project: placental histology in recurrent spontaneous and indicated preterm birth. Am J Obstet Gynecol 2006; 195:792.</a></li><li class=\"breakAll\">Baldwin V. Pathology of Multiple Gestation, Springer-Verlag, New York 1994.</li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/189\" class=\"nounderline abstract_t\">Souter VL, Kapur RP, Nyholt DR, et al. A report of dizygous monochorionic twins. N Engl J Med 2003; 349:154.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/190\" class=\"nounderline abstract_t\">Yoon G, Beischel LS, Johnson JP, Jones MC. Dizygotic twin pregnancy conceived with assisted reproductive technology associated with chromosomal anomaly, imprinting disorder, and monochorionic placentation. J Pediatr 2005; 146:565.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/191\" class=\"nounderline abstract_t\">Chen AL, Goldfarb IT, Scourtas AO, Roberts DJ. The histologic evolution of revealed, acute abruptions. Hum Pathol 2017; 67:187.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/192\" class=\"nounderline abstract_t\">Roberts DJ, Ampola MG, Lage JM. Diagnosis of unsuspected fetal metabolic storage disease by routine placental examination. Pediatr Pathol 1991; 11:647.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/193\" class=\"nounderline abstract_t\">Hillier SL, Krohn MA, Kiviat NB, et al. Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 1991; 165:955.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/194\" class=\"nounderline abstract_t\">Beebe LA, Cowan LD, Altshuler G. The epidemiology of placental features: associations with gestational age and neonatal outcome. Obstet Gynecol 1996; 87:771.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/195\" class=\"nounderline abstract_t\">Williams MC, O'Brien WF, Nelson RN, Spellacy WN. Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants. Am J Obstet Gynecol 2000; 183:1094.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/196\" class=\"nounderline abstract_t\">Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol 2004; 190:147.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/197\" class=\"nounderline abstract_t\">Holzman C, Lin X, Senagore P, Chung H. Histologic chorioamnionitis and preterm delivery. Am J Epidemiol 2007; 166:786.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/198\" class=\"nounderline abstract_t\">Hillier SL, Martius J, Krohn M, et al. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319:972.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/199\" class=\"nounderline abstract_t\">Aaltonen R, Heikkinen T, Hakala K, et al. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 2005; 106:802.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/200\" class=\"nounderline abstract_t\">Baergen R, Benirschke K, Ulich TR. Cytokine expression in the placenta. The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition. Arch Pathol Lab Med 1994; 118:52.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/201\" class=\"nounderline abstract_t\">Hagberg H, Wennerholm UB, S&auml;vman K. Sequelae of chorioamnionitis. Curr Opin Infect Dis 2002; 15:301.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/202\" class=\"nounderline abstract_t\">Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007; 65:S194.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/203\" class=\"nounderline abstract_t\">Dong Y, St Clair PJ, Ramzy I, et al. A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol 1987; 70:175.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/204\" class=\"nounderline abstract_t\">Smulian JC, Shen-Schwarz S, Vintzileos AM, et al. Clinical chorioamnionitis and histologic placental inflammation. Obstet Gynecol 1999; 94:1000.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/205\" class=\"nounderline abstract_t\">Mikamo H, Kawazoe K, Sato Y, et al. Preterm labor and bacterial intraamniotic infection: arachidonic acid liberation by phospholipase A2 of Fusobacterium nucleatum. Am J Obstet Gynecol 1998; 179:1579.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/206\" class=\"nounderline abstract_t\">Hill GB. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol 1998; 3:222.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/207\" class=\"nounderline abstract_t\">Kikhney J, von Sch&ouml;ning D, Steding I, et al. Is Ureaplasma spp. the leading causative agent of acute chorioamnionitis in women with preterm birth? Clin Microbiol Infect 2017; 23:119.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/208\" class=\"nounderline abstract_t\">Romero R, Nores J, Mazor M, et al. Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance. J Reprod Med 1993; 38:543.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/209\" class=\"nounderline abstract_t\">Novak RW, Platt MS. Significance of placental findings in early-onset group B streptococcal neonatal sepsis. Clin Pediatr (Phila) 1985; 24:256.</a></li><li><a href=\"https://www.uptodate.com/contents/the-placental-pathology-report/abstract/210\" class=\"nounderline abstract_t\">Udagawa H, Oshio Y, Shimizu Y. Serious group A streptococcal infection around delivery. Obstet Gynecol 1999; 94:153.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2282 Version 34.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H39\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H13522917\" id=\"outline-link-H13522917\">INDICATIONS FOR PLACENTAL PATHOLOGY EXAMINATION</a></li><li><a href=\"#H63689380\" id=\"outline-link-H63689380\">THE PLACENTAL PATHOLOGY REPORT</a><ul><li><a href=\"#H2283755665\" id=\"outline-link-H2283755665\">Overview</a></li><li><a href=\"#H434561749\" id=\"outline-link-H434561749\">Gross description and final diagnosis</a></li></ul></li><li><a href=\"#H1173795429\" id=\"outline-link-H1173795429\">PLACENTAL FINDINGS</a><ul><li><a href=\"#H4072676570\" id=\"outline-link-H4072676570\">Placental maturity and weight</a><ul><li><a href=\"#H2761470833\" id=\"outline-link-H2761470833\">- Maturity</a></li><li><a href=\"#H665901411\" id=\"outline-link-H665901411\">- Weight</a></li></ul></li><li><a href=\"#H2\" id=\"outline-link-H2\">Umbilical cord</a><ul><li><a href=\"#H63689559\" id=\"outline-link-H63689559\">- Cord coiling</a></li><li><a href=\"#H63689566\" id=\"outline-link-H63689566\">- Insertional anomalies</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">- Inflammation</a></li><li><a href=\"#H4261072954\" id=\"outline-link-H4261072954\">- Nonbacterial infection</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- Meconium staining</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Solid and cystic abnormalities</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Arterial and venous thrombosis</a></li><li><a href=\"#H4507457\" id=\"outline-link-H4507457\">- Single umbilical artery</a></li><li><a href=\"#H1173795986\" id=\"outline-link-H1173795986\">- Congenital remnants</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">Membranes</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">- Acute or chronic chorioamnionitis</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Meconium staining</a></li><li><a href=\"#H4505987\" id=\"outline-link-H4505987\">- Hemosiderin staining</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Solid and cystic abnormalities</a></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">Parenchyma</a><ul><li><a href=\"#H18\" id=\"outline-link-H18\">- Villitis</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">Acute villitis</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Lympho-histiocytic (chronic) villitis</a></li></ul></li><li><a href=\"#H4508589\" id=\"outline-link-H4508589\">- Chorangiosis</a></li><li><a href=\"#H4507183\" id=\"outline-link-H4507183\">- Excessive fibrin deposition</a><ul><li><a href=\"#H4507189\" id=\"outline-link-H4507189\">Maternal floor infarction/massive perivillous fibrin deposition</a></li><li><a href=\"#H4507195\" id=\"outline-link-H4507195\">Chronic histiocytic intervillositis</a></li></ul></li><li><a href=\"#H21\" id=\"outline-link-H21\">- Parenchymal infarcts, syncytial knotting, and other lesions associated with malperfusion</a></li><li><a href=\"#H4510265\" id=\"outline-link-H4510265\">- Calcification</a></li><li><a href=\"#H87576228\" id=\"outline-link-H87576228\">- Langhans cells and Hofbauer cells</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">- Fetal vascular malperfusion (FVM), also known as fetal thrombotic vasculopathy</a><ul><li><a href=\"#H4508407\" id=\"outline-link-H4508407\">Thrombi in fetal vessels</a></li><li><a href=\"#H4508414\" id=\"outline-link-H4508414\">Avascular villi</a></li><li><a href=\"#H4508421\" id=\"outline-link-H4508421\">Villous stromal-vascular karyorrhexis</a></li></ul></li><li><a href=\"#H24\" id=\"outline-link-H24\">- Mass lesions of the parenchyma</a><ul><li><a href=\"#H25\" id=\"outline-link-H25\">Intervillous thrombi</a></li><li><a href=\"#H26\" id=\"outline-link-H26\">Chorangioma</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">Metastatic neoplasms</a></li><li><a href=\"#H87585479\" id=\"outline-link-H87585479\">Choriocarcinoma</a></li></ul></li></ul></li></ul></li><li><a href=\"#H32\" id=\"outline-link-H32\">SELECTED DISORDERS OF PERINATAL AND MEDICOLEGAL IMPORTANCE</a><ul><li><a href=\"#H33\" id=\"outline-link-H33\">Acute versus chronic stress/insult</a></li><li><a href=\"#H2951801940\" id=\"outline-link-H2951801940\">Preeclampsia</a></li><li><a href=\"#H87576122\" id=\"outline-link-H87576122\">Intrauterine growth restriction</a></li><li><a href=\"#H87576091\" id=\"outline-link-H87576091\">Neurologically impaired infant</a></li><li><a href=\"#H37\" id=\"outline-link-H37\">Recurrent preterm birth</a></li><li><a href=\"#H38\" id=\"outline-link-H38\">Multiple gestation</a></li><li><a href=\"#H4506339\" id=\"outline-link-H4506339\">Abruptio placenta</a></li><li><a href=\"#H87575936\" id=\"outline-link-H87575936\">Inborn errors of metabolism</a></li><li><a href=\"#H87576253\" id=\"outline-link-H87576253\">Chorioamnionitis</a><ul><li><a href=\"#H87579796\" id=\"outline-link-H87579796\">- Candida</a></li><li><a href=\"#H87579823\" id=\"outline-link-H87579823\">- Fusobacterium</a></li><li><a href=\"#H87583059\" id=\"outline-link-H87583059\">- Mycoplasma hominis and Ureaplasma urealyticum</a></li></ul></li><li><a href=\"#H87581300\" id=\"outline-link-H87581300\">Streptococcal infections</a></li></ul></li><li><a href=\"#H39\" id=\"outline-link-H39\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"OBGYN/2282|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/93966\" class=\"graphic graphic_figure\">- Umbilical cord coiling patterns</a></li></ul></li><li><div id=\"OBGYN/2282|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/62758\" class=\"graphic graphic_picture\">- Terminal villi</a></li><li><a href=\"image.htm?imageKey=OBGYN/72450\" class=\"graphic graphic_picture\">- Villous maturational arrest</a></li><li><a href=\"image.htm?imageKey=OBGYN/74438\" class=\"graphic graphic_picture\">- Funisitis</a></li><li><a href=\"image.htm?imageKey=OBGYN/53199\" class=\"graphic graphic_picture\">- Candida placentitis</a></li><li><a href=\"image.htm?imageKey=OBGYN/67487\" class=\"graphic graphic_picture\">- Meconium myonecrosis</a></li><li><a href=\"image.htm?imageKey=OBGYN/70927\" class=\"graphic graphic_picture\">- Hematoma umbilical cord</a></li><li><a href=\"image.htm?imageKey=OBGYN/56907\" class=\"graphic graphic_picture\">- Microscopy cord hematoma</a></li><li><a href=\"image.htm?imageKey=OBGYN/53101\" class=\"graphic graphic_picture\">- Meconium stained membranes</a></li><li><a href=\"image.htm?imageKey=OBGYN/78284\" class=\"graphic graphic_picture\">- Amnion nodosum</a></li><li><a href=\"image.htm?imageKey=OBGYN/56641\" class=\"graphic graphic_picture\">- Neutrophilic villitis and abscess</a></li><li><a href=\"image.htm?imageKey=OBGYN/77237\" class=\"graphic graphic_picture\">- Lymphohistiocytic villitis 2</a></li><li><a href=\"image.htm?imageKey=OBGYN/95039\" class=\"graphic graphic_picture\">- Villitis of unknown etiology</a></li><li><a href=\"image.htm?imageKey=OBGYN/64413\" class=\"graphic graphic_picture\">- Chronic villitis </a></li><li><a href=\"image.htm?imageKey=OBGYN/70713\" class=\"graphic graphic_picture\">- Placental CMV infection</a></li><li><a href=\"image.htm?imageKey=OBGYN/59608\" class=\"graphic graphic_picture\">- Massive perivillous fibrin deposition(maternal floor infarction)</a></li><li><a href=\"image.htm?imageKey=OBGYN/58193\" class=\"graphic graphic_picture\">- Massive chronic intervillositis</a></li><li><a href=\"image.htm?imageKey=OBGYN/51550\" class=\"graphic graphic_picture\">- Maternal vascular malperfusion</a></li><li><a href=\"image.htm?imageKey=OBGYN/94964\" class=\"graphic graphic_picture\">- Distal villous hypoplasia</a></li><li><a href=\"image.htm?imageKey=OBGYN/50997\" class=\"graphic graphic_picture\">- Fetal vascular malperfusion</a></li><li><a href=\"image.htm?imageKey=OBGYN/74960\" class=\"graphic graphic_picture\">- Laminated intervillous thrombus</a></li><li><a href=\"image.htm?imageKey=OBGYN/67130\" class=\"graphic graphic_picture\">- Chorangioma</a></li><li><a href=\"image.htm?imageKey=OBGYN/94965\" class=\"graphic graphic_picture\">- Intravillous hemorrhage</a></li><li><a href=\"image.htm?imageKey=OBGYN/56454\" class=\"graphic graphic_picture\">- Chorioamnionitis</a></li><li><a href=\"image.htm?imageKey=OBGYN/77902\" class=\"graphic graphic_picture\">- Chorioamnionitis 3</a></li><li><a href=\"image.htm?imageKey=OBGYN/50692\" class=\"graphic graphic_picture\">- Severe neutrophilic chorioamnionitis</a></li><li><a href=\"image.htm?imageKey=OBGYN/51447\" class=\"graphic graphic_picture\">- Normal membranes</a></li><li><a href=\"image.htm?imageKey=OBGYN/58878\" class=\"graphic graphic_picture\">- Candidiasis of cord</a></li><li><a href=\"image.htm?imageKey=OBGYN/74230\" class=\"graphic graphic_picture\">- Candidal hyphae in cord</a></li><li><a href=\"image.htm?imageKey=OBGYN/53331\" class=\"graphic graphic_picture\">- Fusobacterium chorioamnionitis</a></li></ul></li><li><div id=\"OBGYN/2282|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/72177\" class=\"graphic graphic_table\">- Placental weight</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=care-of-the-umbilicus-and-management-of-umbilical-disorders\" class=\"medical medical_review\">Care of the umbilicus and management of umbilical disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fetal-growth-restriction-evaluation-and-management\" class=\"medical medical_review\">Fetal growth restriction: Evaluation and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gestational-trophoblastic-disease-pathology\" class=\"medical medical_review\">Gestational trophoblastic disease: Pathology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gross-examination-of-the-placenta\" class=\"medical medical_review\">Gross examination of the placenta</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=massive-fetomaternal-hemorrhage\" class=\"medical medical_review\">Massive fetomaternal hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placental-abruption-clinical-features-and-diagnosis\" class=\"medical medical_review\">Placental abruption: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=placental-pathology-in-cases-of-neurologically-impaired-infants\" class=\"medical medical_review\">Placental pathology in cases of neurologically impaired infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prenatal-diagnosis-and-management-of-umbilical-cord-abnormalities\" class=\"medical medical_review\">Prenatal diagnosis and management of umbilical cord abnormalities</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=single-umbilical-artery\" class=\"medical medical_review\">Single umbilical artery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=twin-pregnancy-labor-and-delivery\" class=\"medical medical_review\">Twin pregnancy: Labor and delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=velamentous-umbilical-cord-insertion-and-vasa-previa\" class=\"medical medical_review\">Velamentous umbilical cord insertion and vasa previa</a></li></ul></div></div>","javascript":null}